Academic Cardiology.doc
Upcoming SlideShare
Loading in...5
×
 

Academic Cardiology.doc

on

  • 1,301 views

 

Statistics

Views

Total Views
1,301
Slideshare-icon Views on SlideShare
1,301
Embed Views
0

Actions

Likes
0
Downloads
4
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft Word

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Academic Cardiology.doc Academic Cardiology.doc Document Transcript

    • Academic Cardiology Departmental Publications 2001-2008 (Categorised by 2006 Impact Factor) New Engl J Med (51.296) 2007 Kjekshus J, Apetrei E, Barrios V, Böhm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Jánosi A,Kamenský G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ,Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J; CORONA Group. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007 Nov 29;357(22):2248-61. Epub 2007 Nov 5. Cleland JG, Tendera M, Taylor J. Prognosis in heart failure with a normal ejection fraction. N Engl J Med 2007 Aug 23; 357(8): 829-30. 2005 Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, for the Cardiac Resynchronization – Heart Failure (CARE-HF) Study Investigators. The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure. N Engl J Med. 2005 Mar 7; 352: 1539-49. Lancet (25.800) 2007 Cleland JG, Atkin SL. Thiazolidinediones, Deadly Sins, Surrogates and Elephants. Lancet 2007: Sep 29;370(9593):1103-4. 2004 Whitby EH, Griffiths PD, Rutter S, Sprigg A, Smith MF, Ohadike P, Davies NP, Rigby AS, Paley MN. Frequency and natural history of subdural haemorrhages in babies and relation to obstetric factors. Lancet 2004: 362 : 846-851 2003 Cleland JG, Freemantle N. The CHARM programme. Lancet. 2003 Nov 15;362(9396):1679. Cleland JG, Pennell DJ, Ray SG, Coats AJ, Macfarlane PW, Murray GD, Mule JD, Vered Z, Lahiri A; Carvedilol hibernating reversible ischaemia trial: marker of success investigators. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomized controlled trial. Lancet. 2003 Jul 5;362(9377):14-21.
    • Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A; Carvedilol Or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003 Jul 5;362(9377):7-13. Hoye A, Clark A Iatrogenic hyperkalaemia Lancet. 2003 Jun 21;361(9375):2124 2002 Cleland JGF No reduction in cardiovascular risk with NSAIDs – including aspirin? Lancet 2002; 359; 9301: 92-93 Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L, Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002 Jul 20;360(9328):196-202 Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, Freemantle N, Gavazzi A, van Gilst WH, Hobbs FD, Korewicki J, Madeira HC, Preda I, Swedberg K, Widimsky J, Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet. 2002 Nov 23;360(9346):1631-9 JAMA (23.175) 2007 McMurray JJV, Teerlink JR, Cotter G, Bourge RC, Cleland JGF et al. Effects of Tezosentan or Symptoms and Clinical Outcomes in Patients with Acute Heart Failure. The VERITAS Randomized Controlled Trials. JAMA 2007; 298 (17): 2009-2019. 2003 Cleland JG, Freemantle N. Cardiac resynchronization for progressive heart failure. JAMA. 2003 Jul 2;290(1):36-7; author reply 37-8. Ann Intern Med (14.780) 2005 Calvert M, Freemantle N, Cleland JG. Cardiac resynchronization therapy in heart failure. Ann Intern Med 2005 Feb 15;142(4):305-7; author reply 307-8. 2001 Massie BM, Armstrong PW, Cleland JG, Horowitz JD, Packer M, Poole-Wilson PA et al. Toleration of high doses of angiotensin-converting enzyme inhibitors in patients 2
    • with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival. Arch Intern Med 2001; 161(2):165-171. Circulation (10.940) 2007 Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JG, Carson PE, Maggioni AP, Mann DL, Pitt B, Poole-Wilson P A, Levy WC. Prediction of Mode of Death in Heart Failure: the Seattle Heart Failure Model Circulation 2007 Jul 24;116 (4):392-8. [Epub 2007 Jul 9] 2006 Hoppe UC, Casares JM, Eiskjaer H, Hagemann A, Cleland JGF, Freemantle N, Erdmann E. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation 2006; 114 (1) : 18-25 [Epub ahead of print Jun 26] 2005 Radford MJ, Arnold JM, Bennett SJ, Cinquegrani MP, Cleland JG, Havranek EP,Heidenreich PA, Rutherford JD, Spertus JA, Stevenson LW, Goff DC, Grover FL,Malenka DJ, Peterson ED, Redberg RF; American College of Cardiology; American Heart Association Task Force on Clinical Data Standards; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Failure Society of America. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Heart Failure Clinical Data Standards): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Failure Society of America. Circulation. 2005 Sep 20;112(12):1888-916. Epub 2005 Sep 14. No abstract available. Clark AL, Cleland JG. Anemia and chronic heart failure: are we asking the right questions? Circulation. 2005 Sep 20;112(12):1681-3. No abstract available. Stone GW, Reifart NJ, Moussa I, Hoye A, Cox DA, Colombo A, Baim DS, Teirstein PS, Strauss BH, Selmon M, Mintz GS, Katoh O, Mitsudo K, Suzuki T, Tamai H, Grube E, Cannon LA, Kandzari DE, Reisman M, Schwartz RS, Bailey S, Dangas G, Mehran R, Abizaid A, Moses JW, Leon MB, Serruys PW Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II Circulation. 2005 Oct 18;112(16):2530-7 Stone GW, Kandzari DE, Mehran R, Colombo A, Schwartz RS, Bailey S, Moussa I, Teirstein PS, Dangas G, Baim DS, Selmon M, Strauss BH, Tamai H, Suzuki T, Mitsudo K, Katoh O, Cox DA, Hoye A, Mintz GS, Grube E, Cannon LA, Reifart NJ, Reisman M, Abizaid A, Moses JW, Leon MB, Serruys PW Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I Circulation. 2005 Oct 11;112(15):2364-72 3
    • Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W, Bonnier J, Lablanche JM, Siminiak T, Nordrehaug J, Figulla H, Drzewiecki J, Banning A, Hauptmann K, Dudek D, Bruining N, Hamers R, Hoye A, Ligthart JM, Disco C, Koglin J, Russell ME, Colombo A Incomplete Stent Apposition After Implantation of Paclitaxel-Eluting Stents or Bare Metal Stents. Insights From the Randomized TAXUS II Trial Circulation 2005 Feb 14th; epub 2004 Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ, McFadden E, Sianos G, Smits PC, Hofma SH, de Feyter PJ, van Domburg RT, Serruys PW Clinical, Angiographic, and Procedural Predictors of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Complex Patients: an Evaluation from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) Study Circulation 2004 Mar 23;109(11):1366-70 Lemos PA, Serruys PW, Van Domburg RT, Saia F, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Daemen J, Liu TK, McFadden E, Sianos G, Hofma SH, Smits PC, Van Der Giessen WJ, De Feyter PJ Unrestricted Utilization of Sirolimus- Eluting Stents Compared With Conventional Bare Stent Implantation in the "Real World." The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry Circulation. 2004 Jan 20;109(2):190-5 Lemos PA, Van Mieghem CA, Arampatzis CA, Hoye A, Ong AT, McFadden E, Sianos G, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW Post-Sirolimus- Eluting Stent Restenosis Treated with Repeat Percutaneous Intervention. Late Angiographic and Clinic Outcomes Circulation, 2004 Jun 1;109(21):2500-2 2003 Saia F, Lemos PA, Lee CH, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Sianos G, Smits PC, McFadden E, Hofma SH, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study Circulation. 2003 Oct 21;108(16):1927-9 Lemos PA, Saia F, Ligthart JM, Arampatzis CA, Sianos G, Tanabe K, Hoye A, Degertekin M, Daemen J, McFadden E, Hofma S, Smits PC, de Feyter P, van der Giessen WJ, van Domburg RT, Serruys PW Coronary restenosis after sirolimus- eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Circulation. 2003 Jul 22;108(3):257-60 2001 Clark AL. Impairment of ventilatory efficiency in heart failure. Circulation. 2001 May 8;103(18):E97-7. 4
    • J Am Coll Cardiol (9.701) 2008 Cleland JG, Freemantle N, Ghio S, Fruhwald F, Shankar A, Marijianowski M, Verboven Y, Tavazzi L. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response: A report from the CARE-HF (Cardiac Resynchronisation in Heart Failure) Trial. J Am Coll Cardiol 2008: in press. 2007 Remme WJ, Torp-Pedersen C, Cleland JG, Poole-Wilson P A, Metra M, Komajda M, Swedberg K, Di Lenarda A, Spark P, Scherhag A, Moullet C, Lukas MA. Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET. J Am Coll Cardiol 2007; Mar 6; 49(9): 963-71. [Epub 2007 Feb 20] 2006 Witte KK, Clark AL. Chronotropic incompetence in heart failure. J Am Coll Cardiol. 2006 Aug 1;48(3):595; author reply 595-6. [Epub 2006 Jul 12]. Cleland JG,Charlesworth A , Lubsen J , Swedberg K , Remme W , Erhardt L , Di Lenarda A, Komajda M , Metra M , Torp-Pedersen C , Poole-Wilson P. A Comparison of the Effects of Carvedilol and Metoprolol on 'Well-being', Morbidity and Mortality (The Patient-Journey) in Patients with Heart Failure: A report from the Carvedilol or Metoprolol European Trial (COMET) J Am Coll Cardiol 2006 Apr 18; 47(8):1603-11. [Epub 2006 Mar 29]. Ingle L, Reddy P, Clark AL, Cleland JG. Diabetes lowers 6-min walk test performance in heart failure. J Am Coll Cardiol 2006 May 2; 47(9): 1909-10. Hoye A, Iakovou I, Ge L, van Mieghem CA, Ong ATL, Cosgrave J, Sangiorgi GM, Airoldi F, Montorfano M, Michev I, Chieffo A, Carlino M, Corvaja N, Aoki J, Rodriguez Granillo G, Valgimigli M, Sianos G, van der Giessen WJ, de Feyter P, van Domburg RT, Colombo A, Serruys PW Long-term Outcomes Following Stenting of Bifurcation Lesions Utilizing the “Crush” Technique: Predictors of an Adverse Outcome J Am Coll Cardiol, 2006 May 16;47(10):1949-58. Epub 2006 Apr 24. 2005 Cleland JG, Louis AA, Rigby AS, Janssens U, Balk AH; TEN-HMS Investigators. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol. 2005 May 17;45(10):1654-64. Epub 2005 Apr 22. Ong AT, Serruys PW, Aoki J, Hoye A, van Mieghem CA, Rodriguez-Granillo GA, Valgimigli M, Sonnenschein K, Regar E, van der Ent M, de Jaegere PP, McFadden EP, Sianos G, van der Giessen WJ, de Feyter PJ, van Domburg RTThe unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam 5
    • Cardiology Hospital (T-SEARCH) registry J Am Coll Cardiol. 2005 Apr 5;45(7):1135-41 Ong AT, Hoye A, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Sonnenschein K, Regar E, McFadden EP, Sianos G, van der Giessen WJ, de Jaegere PP, de Feyter P, van Domburg RT, Serruys PW Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation J Am Coll Cardiol. 2005 Mar 15;45(6):947-53. 2004 Hoye A, Tanabe K, Lemos PA, Aoki J, Saia F, Arampatzis CA, Degertekin M, Hofma SJ, Sianos G, McFadden E, van der Giessen WJ, Smits PC, de Feyter PJ, van Domburg RT, Serruys PWSignificant Reduction in Restenosis After the Use of Sirolimus-Eluting Stents in the Treatment of Chronic Total Occlusions J Am Coll Cardiol 2004 Jun;43(11):1954-8 Lemos PA, Saia F, Hofma SJ, Daemen J, Ong ATL, Arampatzis CA, Hoye A, McFadden E, Sianos G, Smits PC, van der Giessen WJ, de Feyter P, van Domburg RT, Serruys PW Short- and Long-Term Clinical Benefit of Sirolimus- Eluting Stents Compared to Conventional Bare Stents for Patients With Acute Myocardial Infarction J Am Coll Cardiol 2004 Feb 18;43(4):704-8 2003 Khand AU, Rankin AC, Martin W, Taylor J, Gemmell I, Cleland JG. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol. 2003 Dec 3;42(11):1944-51. Rauchhaus M, Clark AL, Doehner W, Davos C, Bolger A, Sharma R, Coats AJ, Anker SD. The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol. 2003 Dec 3;42(11):1933-40. Cleland JG, Clark AL. Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth. J Am Coll Cardiol. 2003 Oct 1;42(7):1234-7. Lemos PA, Lee CH, Degertekin M, Saia F, Tanabe K, Arampatzis CA, Hoye A, van Duuren M, Sianos G, Smits PC, de Feyter P, van der Giessen WJ, van Domburg RT, Serruys PW Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry J Am Coll Cardiol. 2003 Jun 4;41(11):2093-9 2002 Banerjee P, Banerjee T, Khand A, Clark AL, Cleland JGF. Diastolic Heart Failure: Neglected or Misdiagnosed? J Am Coll Cardiol 2002; 39: 138-141. 6
    • 2001 Witte KKA, Clark AL, Cleland JGF. Chronic Heart Failure and Micronutrients. 2001; J Am Coll Cardiol 37, No 7: 1765-1774. BMJ (9.245) 2007 Clark RA, Inglis SC, McAlister FA, Cleland JGF, Stewart S. Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ 2007: May 5;334(7600): 942. [Epub 2007 Apr 10] 2003 Kaye GC. Percutaneous interventional electrophysiology. BMJ 2003 Aug 2; 327 (7409) : 280-3. Houghton T, Kaye GC. Implantable devices for treating tachyarrhythmias. BMJ 2003 Aug 9: 327 (7410): 333-6. 2002 Cleland JGF. For Debate: Preventing atherosclerotic events with aspirin. BMJ 2002; 324: 103-105. Cleland JGF. Chronic aspirin is effective – if data are massaged sufficiently. BMJ 2002; 324: (7332): 295. MacGregor AJ, Lanchbury J, Rigby AS, Kaprio K, Sneider H. Using twin studies to label disease as genetic or environmental is inappropriate (Letter). BMJ 2002: 324 : 1100-1101 2001 Cleland JGF, Kaye GC. Long-term anticoagulation or antiplatelet treatment. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation. BMJ 2001; 323(7306):233-discussion 235-6. Diabetes (7.955) 2006 Kilpatrick E, Rigby AS, Atkin S The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes 2006 Jul;29(7):1486-90. Diabetes Care (7.912) 2007 Hoppe UC, Freemantle N, Cleland JGF, Marijianowski M, Erdmann E. Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with 7
    • severe heart failure. Diabetes Care 2007; Mar;30(3):722-4. 2006 Kilpatrick E, Rigby AS, Atkin S. Insulin resistance, the metabolic syndrome and the complication risk in type I diabetes: ‘double diabetes’ in the DCCT. Diabetes Care 2006 Mar; 30 (3): 707-12. European Heart Journal (7.286) 2008 Rivero-Ayerza M, Scholte op Reimer W, Lenzen M, Theuns DAMJ, Jordaens L, Komajda M, Follath F, Swedberg K, Cleland JGF. New onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey. Eur Heart J 2008 Jul; 29 (13): 1618-24. Torabi A, Cleland JGF, Khan NK, Loh PH, Clark AL, Alamgir F, Caplin JL, Rigby AS, Goode KM. The timing of development and subsequent clinical course of heart failure after a myocardial infarction. Eur Heart J 2008 Apr; 29 (7): 859-70. Zannad F, Gattis Stough W, Pitt B, Cleland JGF, Adams KF, Geller NL, Torp- Pedersen C, Kirwan B-A, Follath F. Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition. Eur Heart J 2008; 29: 413-421. Pang PS, Cleland JGF, Teerlink JR, Collins SP, Lindsell CJ, Sopko G, Peacock WF, Fonarow GC, Aldeen AZ, Kirk JD, Storrow AB, Tavares M, Mebazaa A, Roland E, Massie BM, Maisel AS, Komajda M, Filippatos G, Gheorghiade M, for the Acute Heart Failure Syndromes International Working Group. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J 2008 Mar; 29(6): 816-24. 2007 van Veldhuisen DJ, Dickstein K, Cohen-Solal A, Lok DJ, Wasserman SM, Baker N, Rosser D, Cleland JG, Ponikowski P. Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia. Eur Heart J. 2007 Aug 6; [Epub ahead of print] Authors/Task Force Members, Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, Gasparini M, Linde C, Morgado FB, Oto A, Sutton R,Trusz-Gluza M; ESC Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL; Document Reviewers, Priori SG, Blomstrom-Lundqvist C, Brignole M, Terradellas JB, Camm J, Castellano P, Cleland J, Farre J, Fromer M, Le Heuzey JY, Lip GY, Merino JL, Montenero AS, Ritter P, Schalij MJ, Stellbrink C.Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac 8
    • Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association. Eur Heart J. 2007 Aug 28; [Epub ahead of print] No abstract available. Ingle L, Rigby AS, Carroll S, Butterly R, King RF, Cooke CB, Cleland JG, Clark AL. Prognostic value of the 6-minute walk test and self-perceived symptom severity in older patients with chronic heart failure. Eur Heart J 2007: Mar; 28(5):560-8. [Epub ahead of print Feb 21] Fruhwald F, Fahrleitner-Pammer A, Berger R, Leyva F, Freemantle N, Erdmann E, Gras D, Kappenberger L, Tavazzi L, Daubert J-C, Cleland JGF. Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. Eur Heart J 2007 Jul; 28 (13): 1592-7 [Epub ahead of print] Richardson M, Freemantle N, Calvert MJ, Cleland JG, Tavazzi L. Predictors and Treatment Response with Cardiac Resynchronisation Therapy in Patients with Heart Failure Characterised by Dyssynchrony: A Predefined Analysis from the CARE-HF Trial. Eur Heart J 2007 Aug; 28(15):1827-34 [Epub ahead of print May 31]. Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J. 2007 Jan 28; 28(1) : 42-51 [Epub ahead of print Nov 16] Komajda M, Hanon O, Hochadel M, Follath F, Swedberg K, Gitt A, Cleland JGF. Management of octogenarians hospitalized for heart failure in EuroHeart Failure Survey I. Eur Heart J 2007 Jun. 28 (11): 1310-8 [Epub ahead of print Dec 21 2006] 2006 Shelton RJ, Clark AL, Goode K, Rigby AS, Cleland JGF. The diagnostic utility of N- terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Eur Heart J 2006; 27: 2353-2361. Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. Longer-term effects of Cardiac Resynchronisation Therapy on Mortality in Heart Failure (the Cardiac REsynchronisation – Heart Failure (CARE-HF) Trial Extension Phase. Eur Heart J 2006; 27:16 (Aug) :1928-1932 [Epub ahead of print Jun 16] Also published in Asian/African Excerpted Edition 2006; 1 (3). Komajda M, Anker S, Charlesworth A, Okonko D, Metra M, Di Lenarda A, Remme W, Moullet C, Swedberg K, Cleland JGF, Poole-Wilson PA. The impact of new onset anaemia on morbidity and mortality in chronic heart failure; results from COMET. Eur Heart J 2006; 27 (12): 1440-6. 9
    • Cleland JGF, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J on behalf of PEP-CHF Investigators. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006: 27: 2338-2345. Cleland JG, Goode K, Khaleva O, Khan N. How many patients need Cardiac Resynchronisation Therapy? Eur Heart J 2006 Feb; 27/3): 251-2. [Epub 2005 Dec 7]. Cleland JG, Loh H, Windram J, Goode K, Clark AL. Threats, opportunities and statins in the modern management of heart failure. Eur Heart J 2006 Mar; 27(6): 641-3. de Silva R, Nikitin NP, Witte KK, Rigby AS, Goode K, Bhandari S, Clark AL, Cleland JG. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J. 2006 Mar; 27(5): 569-81. [Epub 2005 Dec 19] Thackray SR, Witte KK, Ghosh J, Nikitin NP, Anderson A, Goode K, Rigby A, Clark AL, Cleland JG. N-terminal Brain Natriuretic Peptide as a Screening Tool for Heart Failure in the Pacemaker Population. Eur Heart J 2006 Feb;27(4): 447-53. [Epub 2005 Nov 18]. 2005 Calvert MJ, Freemantle N, Yao G, Cleland JG, Billingham L, Daubert JC, Bryan S. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. Eur Heart J. 2005 Dec;26(24):2681-8. [Epub 2005 Nov 11]. Cleland JGF, Goode K, Khaleva O, Khan N. How many patients need cardiac resynchronization therapy? Eur Heart J. 2005: Dec 7 [Epub ahead of print] Naka KK, Tweddel AC, Doshi SN, Goodfellow J, Henderson AH. Flow-mediated changes in pulse wave velocity: a new clinical measure of endothelial function. Eur Heart J. 2005 Nov 2; [Epub ahead of print] Hoye A, van Domburg RT, Sonnenschein K, Serruys PW Percutaneous coronary intervention for chronic total occlusions: the Thoraxcenter experience 1992-2002 Eur Heart J. 2005 Dec;26(24):2630-6 Ingle L, Shelton RJ, Rigby AS, Nabb S, Cleland JG, Clark AL. The reproducibility and sensitivity of the six-minute walk test in patients with chronic heart failure. Eur Heart J 2005;Sep;26(17):1742-51 [Epub ahead of print Apr 14] Olsson LG, Swedberg K, Clark AL, Witte KK, Cleland JGF. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 2005; 26(8):778-793 10
    • Swedberg K, Cleland JGF, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth A. Guidelines for the diagnosis and treatment of Chronic Heart Failure: Eur Heart J 2005; 26:1115-1140. Witte KKA, Nikitin NP, parker AC, von Haehling S, Volk H-D, Anker SD, Clark AL, Cleland JGF. The effect of micronutrient supplementation on quality of life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 2005, Nov;26(21):2238-44 [E-pub ahead of print Aug 4 2005]. de Silva R, Nikitin NP, Bhandari S, Nicholson A, Clark AL, Cleland JG. Atherosclerotic renovascular disease in chronic heart failure: should we intervene? Eur Heart J. 2005 Aug;26(16):1596-605. [Epub 2005 May 26] Metra M, Torp-Pedersen C, Swedberg K, Cleland JG, Di Lenarda A, Komajda M,Remme WJ, Lutiger B, Scherhag A, Lukas MA, Charlesworth A, Poole-Wilson PA. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. Eur Heart J. 2005 Nov;26(21):2259-68. Lenzen MJ, Boersma E, Scholte Op Reimer WJ, Balk AH, Komajda M, Swedberg K, Follath F, Jimenez-Navarro M, Simoons ML, Cleland JG. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J. 2005 Sep 23; [Epub ahead of print] Cleland JGF, Goode K, Khaleva O, Khan N. How many patients need Cardiac Resynchronisation Therapy? Eur Heart J 2005 : Dec 7 [Epub ahead of print] Aoki J, Ong AT, Hoye A, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, Schonberger JP, Buller N, Bonser R, Lindeboom W, Unger F, Serruys PW Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trial Eur Heart J. 2005 Aug;26(15):1488-93 2004 Lenzen MJ, Scholte op Reimer WJ, Boersma E, Vantrimpont PJ, Follath F, Swedberg K, Cleland J, Komajda M. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J. 2004 Jul;25(14):1214-20. 2003 Thackray SD, Witte KK, Nikitin NP, Clark AL, Kaye GC, Cleland JG. The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population. Eur Heart J. 2003 Jun;24(12):1143-52. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, Van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, 11
    • Widimsky J, Freemantle N, Eastaugh J, Mason J; Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J. 2003 Mar;24(5):464-74. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J; Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003 Mar;24(5):442-63. Cleland JG, Ghosh J, Khan NK, Ghio S, Tavazzi L, Kaye G. Multi-chamber pacing: a perfect solution for cardiac mechanical dyssynchrony? Eur Heart J. 2003 Mar;24(5):384-90. 2002 Clark AL, Greenstone M. Un bout de souffle: ventilatory support for pulmonary oedema. Eur Heart J. 2002 Sep;23(17):1326-8. 2001 Clark AL, Loebe M, Potapov EV, Egerer K, Knosalla C, Hetzer R, Anker SD. Ventricular assist device in severe heart failure: effects on cytokines, complement and body weight. Eur Heart J. 2001 Dec;22(24):2275-83. Khand AU, Gemmell I, Rankin AC and Cleland JGF. Clinical events leading to the progression of heart failure: insights from a national database of hospital discharges. Eur Heart J 2001; 22 (2): 153-164 Cowburn PJ, Cleland JGF. Endothelin antagonists for chronic heart failure: do they have a role? Eur Heart J 2001; Oct;22(19):1772-84. Cleland JGF, Louis A and Witte K. Pharmacoeconomics in heart failure: impact of drug and non-drug based treatment. Eur Heart J 2001; 3 (supplement G) : G25- G32. Cleland JGF, Thygesen K, Uretsky BF, Armstrong P, Horowitz JD, Massie B, Packer M, Poole-Wilson PA and Ryden L on behalf of the ATLAS investigators. Cardiovascular critical event pathways for the progression of heart failure. A report from the ATLAS study. Eur Heart J 2001 Sep;22(17):1601-12 Clark AL, Cleland JGF. Assessing the effect of exercise training in men with heart failure. Eur Heart J 2001; 22:627-628. Clark AL, Cleland JG. How do you measure exercise capacity in chronic heart failure? Eur Heart J 2001; 22(8):627-628. 12
    • Cleland JGF, Khand A, Clark AC. The heart failure epidemic: exactly how big is it? Eur Heart J 2001; 22(8):623-626 CMAJ (Can Med Assoc J) (6.862) 2005 Cleland JG. Patients with treatable malignant diseases -- including heart failure – are entitled to specialist care. CMAJ. 2005 Jan 18;172(2):207-9. J Hepatol (6.073) 2003 Chambers V, Sutherland L, Palmer K, Dalton A, Rigby AS, Sokol R, Pollitt S, Tanner MS, Gleeson D. Haemochromatosis-associated HFE genotypes in UK blood donors: age-related frequency and phenotypic expression. J Hepatol 2003 : 39 ;925-931 Clin Chem (5.454) 2007 Kilpatrick E, Rigby AS, Atkin SL. Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control. Clin Chem 2007; 53(5) (Mar): 897-901. Curr Pharm Des (5.270) 2004 Tanabe K, Regar E, Lee CH, Hoye A, van der Giessen WJ, Serruys PW Local Drug Delivery Using Coated Stents: New Developments and Future Perspectives Curr Pharm Des 2004;10(4):357-67 J Med Genet (5.087) 2007 Quarrell OWJ, Rigby AS, Barron L, Crow Y, Dalton A, Dennis N, Fryer AE, Heydon F, Kinning E, Lashwood A, Losekoot M, Margerison L, McDonnell S, Morrison PJ, Norman A, Peterson M, Raymond FL, Simpson S, Thompson E, Warner J. Reduced penetrance alleles for Huntington’s disease: a multi-centre direct observational study. J Med Genet 2007; 44:e 68. 2001 Shannon NL, Maltby EL, Rigby AS, Quarrell OWJ, An epidemiological study of Wolf- Hirschhorn Syndrome: life expectancy and cause of mortality. J Medical Genet 2001; 38: 674-679 13
    • J Nucl Med (4.986) 2003 Wright GA, Thackray S, Howey S, Cleland JG. Left ventricular ejection fraction and volumes from gated blood-pool SPECT: comparison with planar gated blood-pool imaging and assessment of repeatability in patients with heart failure. J Nucl Med. 2003 Apr;44(4):494-8. J Mol Cell Cardiol (4.859) 2006 Sample J, Cleland JGF, Seymour A-M L Metabolic remodeling in the aging heart. J Mol Cell Cardiol 2006 ; Jan;40(1):56-63. [Epub 2005 Dec 1]. J Intern Med (4.730) 2006 Loh PH, Louis AA, Windram J, Rigby AS, Cook J, Hurren S, Nikitin NP, CAPLIN J, Cleland JGF. The immediate and long-term outcome of enhanced external counterpulsation in treatment of chronic stable refractory angina. J Int Med 2006; 259:276-284. Loh PH, Rigby AS, Cleland JGF. Randomized trials are essential for device therapy: reply. J Int Med 2006; 260: 282-283. (Letter) . Am J Med (4.518) 2006 Cleland JGF, Coletta AP, Witte KK. Practical Applications of Intravenous Diuretic Therapy in Decompensated Heart Failure. Am J Med 2006; ; Dec;119 (112 Suppl 1): S26-36 2005 Orn S, Cleland JG, Romo M, Kjekshus J, Dickstein K. Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction. Am J Med. 2005 Jul;118(7):752-8 Curr Opin Nephrol Hypertens (4.137) 2001 Cleland JGF, John J, Houghton T. Does aspirin attenuate the effect of angiotensin- converting enzyme inhibitors in hypertension or heart failure? Curr Opin Nephrol Hypertens 2001; 10: 625-631. 14
    • Eur J Nucl Med Mol Imag (4.041) 2004 Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, Kelion AD, AI-Mohammad A, Prvulovich EM, Shaw LJ, Tweddel AC; British Cardiac Society; British Nuclear Cardiology Society; British Nuclear Medicine Society; Royal College of Physicians of London; Royal College of Radiologists. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):261-91. Review. Heart (3.708) 2008 Cleland JGF,Cullington D,Tageldien Abdellah A. CRT Upgrade and Occurrence of Ventricular Arrhythmia. Letter. Heart 2008; 94 (6): Cleland JGF, Tageldien A, Maarouf N, Hobson N. Patients with heart failure who require an implantable defibrillator should have cardiac resynchronization routinely. Heart 2008 Aug; 94 (8): 963-6. Cleland JGF, Freemantle N, Daubert JC, Toff W, Leisch F, Tavazzi L. Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF Study. Heart 2008; 94(3):278-283 [Epub ahead of print Nov 5]. Lenzen MJ, Rosengren A, Scholte op Reimer WJM, Follath F, Boersma E, Simoons ML, Cleland JG, Komajda M. Management of patients with heart failure in clinical practice: differences between men and women. Heart 2008: Mar;94(3):e10 [Epub ahead of print Jun 17] Nicol ED, Fitall B, Roughton M, Cleland JGF, Dargie HJ, Cowie MR. NHS Heart Failure Survey - a survey of acute heart failure admissions in England, Wales and Northern Ireland. Heart 2008 Feb;94(2):172-7. Epub 2007 Nov 14 2007 Torp-Pedersen C, Metra M, Charlesworth A, Spark P, Lukas MA, Poole-Wilson PA, Swedberg K, Cleland JGF, Di Lenarda A, Remme WJ, Scherhag A, for the COMET Investigators. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure – data from the Carvedilol or Metoprolol European Trial (COMET). Heart 2007 93(8); 968-973. [Epub ahead of print Jan 19] Garg S, Bourantas C, Thackray S. Suspected Coronary Artery Dissection Confirmed Using Optical Coherence Tomography. Heart 2007; in press. 15
    • 2006 Clark AL. Origin of symptoms in chronic heart failure. Heart. 2006 Jan;92(1):12-6. Epub 2005 Sep 13. Review. Prasad SK, Dargie HJ, Smith GC, Barlow MM, Grothues F, Groenning BA, Cleland JGF, Pennell DJ. Comparison of the dual receptor endothelin antagonist enrasentan iwth enalapril in asymptomatic left ventricular systolic dysfunction; a cardiovascular magnetic resonance study. Heart 2006; 92:798-803 Nikitin NP, Loh PH, de Silva R, Ghosh J, Khaleva OY, Goode K, Rigby AS, Alamgir F, Clark AL, Cleland JG. The prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure due to left ventricular function. Heart 2006; 92 (6): 775-779. Clark AL. Exercise and heart failure: assessment and treatment. Heart. 2006 May;92(5):699-703. Witte KK, Nikitin NP, Cleland JG, Clark AL. Excessive breathlessness in patients with ‘diastolic heart failure’. Heart 2006; 92: 1425-1429. [Epub ahead of print Apr 18;]. Velavan P, Khan NK, Rigby AS, Goode K, Komajda M, Follath F, Swedberg K, Madeira H, Clark AL, Cleland JGF. Relationship between severity of left ventricular systolic dysfunction and repolarisation abnormalities on the surface electrocardiogram – a report from the Euro Heart Failure survey. Heart. 2006 Feb; 92(2): 255-6. Witte KK, Cleland JG, Clark AL. Chronic heart failure, chronotropic incompetence and the effects of beta blockade. Heart 2006 Apr; 92(4): 481-6. [Epub 2005 Sep 13]. Shelton RJ, Rigby AS, Cleland JG, Clark AL. Effect of a community heart failure clinic on the uptake of {beta}-blockers in patients with obstructive airways disease and heart failure. Heart. 2006 Mar; 92(3): 331-6. [Epub 2005 Jun 10]. 2005 Clark AL. Origin of symptoms in chronic heart failure. Heart. 2005 Sep 13; [Epub ahead of print] Witte KK, Clark AL. Cycle exercise causes a lower ventilatory response to exercise in chronic heart failure. Heart. 2005 Feb;91(2):225-6. Cleland J. Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction. Heart 2005 Cleland JG, Torabi A, Khan NK. Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction. Heart. 2005 May;91 Suppl 2:ii7-13; discussion ii31, ii43-8. 16
    • Clark AL, Cleland JG. Multidisciplinary interventions in heart failure. Heart. 2005 Jul;91(7):849-50 Witte KK, Cleland JG, Clark AL. Chronic heart failure, chronotropic incompetence, and the effects of beta-blockade. Heart. 2005 Sep 13; [Epub ahead of print] Anagnostopoulos C, Davies G, Flint J, Harbinson M, Hilson A, Kelion A, Lahiri A, Lim E, Prvulovich L, Sabharwal N, Tweddel A, Underwood R, Woldman S; British Cardiac Society; British Nuclear Cardiology Society; British Nuclear Medicine Society. Setting up a myocardial perfusion scintigraphy service: clinical and business aspects. Heart. 2005 Sep;91 Suppl 4:iv6-14. Review. Sianos G, Hoye A, Saia F, van der Giessen W, Lemos P, de Feyter PJ, Levendag PC, van Domburg R, Serruys PW Long term outcome after intracoronary beta radiation therapy Heart. 2005 Jul;91(7):942-7 2004 Nikitin NP, de Silva R, Cleland JG. The utility of a comprehensive cardiac magnetic resonance examination for the evaluation of patients with heart failure. Heart. 2004 Oct;90(10):1166. Witte KK, Nikitin NP, De Silva R, Cleland JG, Clark AL. Exercise capacity and cardiac function assessed by tissue Doppler imaging in chronic heart failure. Heart. 2004 Oct;90(10):1144-50. Banerjee P, Houghton T, Walters M, Kaye GC. Giant right coronary artery aneurysm presenting as a mediastinal mass. Heart 2004 Sep; 90 (9) : e50. Bellenger NG, Rajappan K, Rahman SL, Lahiri A, Raval U, Webster J,Murray GD, Coats AJ, Cleland JG, Pennell DJ; CHRISTMAS Study Steering Committee and Investigators. Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study. Heart. 2004 Jul;90(7):760-4. Saia F, Lemos PA, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Sianos G, Smits PC, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Heart. 2004 Oct;90(10):1183-8. 2003 Witte KK, Thackray SD, Nikitin NP, Cleland JG, Clark AL. The effects of alpha and beta blockade on ventilatory responses to exercise in chronic heart failure. Heart. 2003 Oct;89(10):1169-73. 17
    • Witte KK, Thackray SD, Nikitin NP, Cleland JG, Clark AL. Pattern of ventilation during exercise in chronic heart failure. Heart. 2003 Jun;89(6):610-4. Poole-Wilson PA, Uretsky BF, Thygesen K, Cleland JG, Massie BM, Ryden L; Atlas Study Group. Assessment of treatment with lisinopril and survival. Mode of death in heart failure: findings from the ATLAS trial. Heart. 2003 Jan;89(1):42-8. 2002 Muir DF, Jummun M, Stewart DJ, Clark AL. Diagnostic accuracy of technician supervised and reported exercise tolerance tests. Heart. 2002 Apr;87(4):381-2. Cleland JG, Contemporary management of heart failure in clinical practice. Heart. 2002 Oct;88 Suppl 2:ii5-8 Am Heart J (3.514) 2007 Loh PH , Windram J, Tin L, Reddy P, Velavan P, Rigby AS, Atkin P, Nikitin NP, Clark AL and Cleland JGF. The effects of initiation or continuation of statin therapy on cholesterol level and all-cause mortality following the diagnosis of left ventricular systolic dysfunction. Am Heart J 2007; 153:537-44. Windram JD, Loh Ph, Rigby AS, Hanning I, Clark AL, Cleland JG. Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure. Am Heart J 2007; Jun: 153(6): 1048-55. 2006 Thackray SD, Ghosh JM, Wright GA, Witte KK, Nikitin N P, Kaye GC, Clark AL, Tweddel A, Cleland JGF. The effect of altering heart rate on ventricular function in patients with heart failure treated with beta-blockers. Am Heart J 2006: Oct 152 (4): 713. e9-13. 2005 Torp-Pedersen C, Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A,Hanrath P, Komajda M, Lutiger B, Metra M, Remme WJ, Scherhag A, Skene A; COMET Investigators. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET. Am Heart J. 2005 Feb;149(2):370-6. Teerlink JR, McMurray JJ, Bourge RC, Cleland JG, Cotter G, Jondeau G, Krum H, Metra M, O'Connor CM, Parker JD, Torre-Amione G, Van Veldhuisen DJ, Frey A, Rainisio M, Kobrin I; VERITAS Investigators. Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS). Am Heart J. 2005 Jul;150(1):46-53. 2004 Cleland JG, Findlay I, Jafri S, Sutton G, Falk R, Bulpitt C, Prentice C, Ford I, Trainer A, Poole-Wilson PA. The Warfarin/Aspirin Study in Heart failure (WASH): a 18
    • randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J. 2004 Jul;148(1):157-64. Witte KK, Desilva R, Chattopadhyay S, Ghosh J, Cleland JG, Clark AL. Are hematinic deficiencies the cause of anemia in chronic heart failure? Am Heart J. 2004 May;147(5):924-30. 2003 McGowan JH, Cleland JG. Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods. Am Heart J. 2003 Sep;146(3):388-97. Obstet Gynecol Surv (3.329) 2004 Whitby EH, Griffiths PD, Rutter S, Smith MF, Spriff A, Ohadike P, Davies NP, Rigby AS, Paley MN. Frequency and natural history of subdural hemorrhages in babies and relation to obstetric factors. Obstet Gynecol Surv, 2004 Dec, 59 (12):814-816 J Cardiovasc Electrophysiol (3.265) 2002 Cleland JGF, Thackray S, Goodge L, Kaye GC, Cooklin M. Outcome studies with device therapy in patients with heart failure. J Cardiovasc Electrophysiol 2002;13: (1 Suppl): S73-91. Clin Sci (3.263) 2003 Vinereanu D, Nicolaides E, Tweddel AC, Madler CF, Hoist B, Boden LE, Cinteza M, Rees AE, Fraser AG. Subclinical left ventricular dysfunction in asymptomatic patients with Type II diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci (Lond). 2003 Nov;105(5):591-9. Eur J Heart Fail (3.242) 2008 Coletta AP, Cleland JG, Cullington D, Clark AL. Clinical trials update from Heart Rhythm 2008 and Heart Failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452. Eur J Heart Fail 2008 Aug; in press. Swedberg K, Cleland JGF, Cowie MR, Nieminen MS, Priori SG, Tavazzi L, van Veldhuisen DJ, Alonso-Pulpon L, Camm J, Dickstein K, Drexler H, Filippatos G, Linde C, Lopen-Sendon J, Santini M, Zannad F. Successful treatment of heart failure with devices requires collaboration. Eur J Heart Fail 2008; in press. 19
    • Nieminen MS, Cleland JFG, Eha J, Belenkov Y, Kivikko M, Pöder P, Sarapohja T. Oral levosimendan in patients with severe chronic heart failure – the PERSIST study. Eur J Heart Fail 2008; in press. Cleland JGF, Coletta AP, Yassin A, Hado H, Cullington D, Tageldien A, Clark AL. Clinical trials update from the American College of Cardiology 2008: CARISMA, TRENDS, meta-analysis of Cox-2 studies, HAT, ON-TARGET, HYVET, ACCOMPLISH, MOMENTUM, PROTECT, HORIZON-HF and REVERSE. Eur J Heart Fail 2008: 10(6): 614-20. Clark AL, Goode K, Cleland JG.The prevalence and incidence of left bundle branch block in ambulant patients with chronic heart failure. Eur J Heart Fail. 2008 Jul; 10(7): 696-702. [Epub May 22] Cleland JGF, Coletta AP, Abdellah AT, Cullington D, Clark AL, Rigby AS. Clinical Trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy. Eur J Heart Fail 2008; 10 (1): 102-108 Chattopadhyay S, Alamgir MF, Nikitin N P, Fraser AG, Clark AL, Cleland JG. The effect of pharmacological stress on intraventricular dyssynchrony in left ventricular systolic dysfunction. Eur J Heart Fail 2008 Apr; 10(4): 412-20. Ingle L, Witte KK, Cleland JGF, Clark AL. Combining the ventilatory response to exercise and peak oxygen consumptioin is no better than peak oxygen consumption alone in predicting mortality in chronic heart failure. Eur J Heart Fail. 2008 Jan;10(1):85-8 2007 Goode KM, Clark AL, Bristow JA, Sykes KB and Cleland JGF. Screening for left ventricular systolic dysfunction in high-risk patients in primary care: a cost-benefit analysis. Eur J Heart Fail 2007: 9 (12) 1186-95. [Epub 2007 Nov 19]. Remme WJ, Cleland JG, Erhardt L, Spark P, Torp-Pedersen C, Metra M, Komajda M, Moullet C, Lukas MA, Poole-Wilson P, Di Lenarda A, Swedberg K. Effect of carvedilol and metoprolol on the mode of death in patients with heart failure. Eur J Heart Fail. 2007 Aug 21; [Epub ahead of print] Olsson LG, Swedberg K, Cleland JG, Spark PA, Komajda M, Metra M, Torp-Pedersen C, Remme WJ, Scherhag A, Poole-Wilson P; on behalf of the COMET investigators. Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: Results from the Carvedilol Or Metoprolol European Trial (COMET) trial. Eur J Heart Fail. 2007 Aug;9(8):795-801. 20
    • Metra M, Torp-Pedersen C, Cleland JG, Di Lenarda A, Komajda M, Remme WJ, Dei Cas L, Spark P, Swedberg K, Poole-Wilson P A, for the COMET Investigators. Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. Eur J Heart Fail; 2007 Sep; 9 (9) : 901-909. [Epub ahead of print Jun 18] Witte KK, Levy WC, Lindsay KA, Clark AL. Biomechanical efficiency is impaired in patients with chronic heart failure. Eur J Heart Fail. 2007 Aug;9(8):834-8. Epub 2007 Jun 13. Cleland JG, Coletta AP, Abdellah AT, Witte KK, Hobson N, Clark AL. Clinical Trials Update from Heart Rhythm 2007 and Heart Failure 2007. CARISMA, PREPARE, DAVID II, SAVE-PACE, PROTECT an AREA-IN-CHF. Eur J Heart Fail 2007; 9(8),Jul 16 (Epub ahead of print). Cleland JG, Coletta AP, Clark AL. Clinical trials update from the American College of Cardiology 2007: ALPHA, EVEREST, FUSION II, VALIDD, PARR-2, REMODEL, SPICE, COURAGE, COACH, REMADHE, pro-BNP for the evaluation of dyspnoea and THIS- diet. Eur J Heart Fail 2007 Jun-Jul; 9(6-7): 740-5. [Epub 2007 May 3]. Cleland JG, Coletta AP, Abdellah AT, Nasir M, Hobson N, Freemantle N, Clark AL. Clinical trials update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and percutaneous mitral annuloplasty. Eur J Heart Fail. 2007 Jan;9(1):92-7. Epub 2006 Dec 22. Cleland JG,Shelton R, Nikitin N, Ford S, Frison L, Grind M. Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of Ximelagatran compared to Warfarin on the Incidence of Morbid and fatal events: A report from the SPORTIF III and V Trials. Eur J Heart Fail 2007;9(6-7): 730-9. [Epub ahead of print Mar 13]. Khan NK, Goode KM, Cleland JG, Rigby AS, Freemantle N, Eastaugh J, Clark AL,de Silva R, Calvert MJ, Swedberg K, Komajda M, Mareev V, Follath F; for the EuroHeart Failure Survey Investigators. Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge. Eur J Heart Fail. 2007; 9(5): 491-501. [Epub ahead of print Jan 8] Lainscak M, Cleland JGF, Lenzen MJ, Follath F, Komajda M, Swedberg K. International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: Data from the EuroHeart Failure Survey. Eur J Heart Fail 2007; 9(3): 292-9. [Epub ahead of print Oct 4 2006] 2006 Cleland JGF, Coletta AP, Clark AL. Clinical trials update from the Heart Failure Society of America meeting: FIX-CHF-4, selective cardiac myosin activator and OPT-CHF. Eur J Heart Fail 2006; 8(7): 764-6. Epub ahead of print Oct 13. 21
    • Cleland JGF, Coletta AP, Clark AL. Clinical trials update from the joint European Society and World Congress of Cardiology Meeting: PEP-CHF, ACCLAIM and the HHH study. Eur J Heart Fail 2006; 8 (6): 658-61. [Epub ahead of print Oct 12]. Coletta AP, Tin L, Loh PH, Clark AL, Cleland JG. Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902. Eur J Heart Fail 2006 Aug; 8(5): 547-9. Epub 2006 Aug 1. Ingle L, Rigby AS, Nabb S, Jones PK, Clark AL, Cleland JGF. Clinical determinants of poor six-minute walk test performance in patients with left ventricular systolic dysfunction and no major structural heart disease. Eur J Heart Fail 2006 May; 8(3): 321-5. Cleland JG, Coletta AP, Nikitin N P, Clark AL. Clinical trials update from the American College of Cardiology: Darbepoetin alfa, ASTEROID, UNIVERSE, paediatric carvedilol, UNLOAD and ICELAND. Eur J Heart Fail 2006 May; 8(3): 326-9. Cleland JG, Freemantle N, Coletta AP, Clark AL. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE.Eur J Heart Fail. 2006 Jan;8(1):105-110. Freemantle N, Tharmanathan P, Calvert MJ, Abraham WT, Ghosh J, Cleland JG. Cardiac resynchronization for Patients with Heart Failure due to Left Ventricular Systolic Dysfunction A Systematic Review and Meta-analysis. Eur J Heart Fail 2006;8(4): 433-40. Feb 26 [Epub ahead of print]. Ingle L, Goode K, Rigby AS, Cleland JG, Clark AL. Predicting peak oxygen uptake from 6-min walk test performance in male patients with left ventricular systolic dysfunction. Eur J Heart Fail 2006 Mar; 8(2): 198-202. [Epub 2005 Sep 26] 2005 Shelton RJ, Velavan P, Nikitin NP, Coletta AP, Clark AL, Rigby AS,Freemantle N, Cleland JG. Clinical trials update from the American Heart Association meeting: ACORN-CSD, primary care trial of chronic disease management, PEACE, CREATE, SHIELD, A-HeFT, GEMINI, vitamin E meta-analysis, ESCAPE, CARP, and SCD-HeFT cost-effectiveness study. Eur J Heart Fail. 2005 Jan;7(1):127-35. Cowburn PJ, Cleland JG, McDonagh TA, McArthur JD, Dargie HJ, Morton JJ. Comparison of selective ET(A) and ET(B) receptor antagonists in patients with chronic heart failure. Eur J Heart Fail. 2005 Jan;7(1):37-42. Cleland J. Letter from the outgoing Editor-in-Chief of the European Journal of Heart Failure. Eur J Heart Fail. 2005 Jan;7(1):1-2. 22
    • Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger l, Klein W, Tavazzi L. On behalf of the CARE-HF study Steering committee and Investigators. Baseline characteristics of patients recruited into the CARE-HF study. Eur J Heart Fail 2005: 205-214. Niebauer J, Clark AL, Webb-Peploe KM, Coats AJ. Exercise training in chronic heart failure: effects on pro-inflammatory markers. Eur J Heart Fail. 2005 Mar 2;7(2):189-93. Niebauer J, Clark AL, Webb-Peploe KM, Boger R, Coats AJ. Home-based exercise training modulates pro-oxidant substrates in patients with chronic heart failure. Eur J Heart Fail. 2005 Mar 2;7(2):183-8. Calvert MJ, Freemantle N, Cleland JG. The impact of chronic heart failure on health- related quality of life data acquired in the baseline phase of the CARE-HF study.Eur J Heart Fail. 2005 Mar 2;7(2):243-51. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Klein W, Tavazzi L; CARE-HF study Steering Committee and Investigators. Baseline characteristics of patients recruited into the CARE-HF study. Eur J Heart Fail. 2005 Mar 2;7(2):205-14. Cleland JGF, Coletta AP, Freemantle N, Velavan P, Tin L, Clark AL. Clinical trials update from the American College of Cardiology meeting: CARE-HF and the Remission of Heart Failure, Women’s Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER. Eur J Heart Fail 2005: 7 (5): 931-6 Witte KK, Thackray S, Nikitin NP, Cleland JG, Clark AL. The effects of long-term beta-blockade on the ventilatory responses to exercise in chronic heart failure. Eur J Heart Fail. 2005 Jun;7(4):612-7. Di Lenarda A, Remme WJ, Charlesworth A, Cleland JG, Lutiger B, Metra M,Komajda M, Torp-Pedersen C, Scherhag A, Swedberg K, Poole-Wilson PA; COMET investors. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial). Eur J Heart Fail. 2005 Jun;7(4):640-9 Witte KKA, Thackray SDR, Lindsay KA, Cleland JGF, Clark AL. Metabolic gas kinetics depend upon the level of exercise performed. Eur J Heart Fail 2005 Oct;7(6):991-6 Aug 19: E pub ahead of print Hobbs FD, Korewicki J, Cleland JG, Eastaugh J, Freemantle N; IMPROVEMENT Investigators. The diagnosis of heart failure in European primary care: The IMPROVEMENT Programme survey of perception and practice. Eur J Heart Fail. 2005 Aug;7(5):768-79 Ekman I, Cleland JG, Andersson B, Swedberg K. Exploring symptoms in chronic heart failure. Eur J Heart Fail. 2005 Aug;7(5):699-703 23
    • Cleland JG, Coletta AP, Clark AL, Velavan P, Ingle L. Clinical trials update from the European Society of Cardiology Heart Failure meeting and the American College of Cardiology: darbepoetin alfa study, ECHOS, and ASCOT-BPLA. Eur J Heart Fail. 2005 Aug;7(5):937-9. Haworth JE, Moniz-Cook E, Clark AL, Wang M, Waddington R, Cleland JG. Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. Eur J Heart Fail. 2005 Aug;7(5):803-8. Khand AU, Shaw M, Gemmel I, Cleland JG. Do discharge codes underestimate hospitalisation due to heart failure? Validation study of hospital discharge coding for heart failure. Eur J Heart Fail. 2005 Aug;7(5):792-7. Ingle L, Goode K, Rigby AS, Cleland JG, Clark AL. Predicting peak oxygen uptake from 6-min walk test performance in male patients with left ventricular systolic dysfunction. Eur J Heart Fail. 2005 Sep 24; [Epub ahead of print] Cleland JGF, Coletta AP, Lammiman M, Witte KK, Loh H, Nasir M, Clark AL. Clinical trials update from the European Society of Cardiology 2005 Meeting: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE. Eur J Heart Fail 2005; 7: Oct;7(6):1070-5. Vinereanu D, Nicolaides E, Tweddel AC, Fraser AG. "Pure" diastolic dysfunction is associated with long-axis systolic dysfunction. Implications for the diagnosis and classification of heart failure. Eur J Heart Fail. 2005 Aug;7(5):820-8. 2004 Lalukota K, Cleland JG, Ingle L, Clark AL, Coletta AP. Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD. Eur J Heart Fail. 2004 Dec;6(7):953-5. Cleland JG, Goode K, Lalukota K. Diagnosing heart failure in primary care: lessons from EPICA. Eur J Heart Fail. 2004 Oct;6(6):793-4. Cleland JG, Huan Loh P, Freemantle N, Clark AL, Coletta AP. Clinical trials update from the European Society of Cardiology: SENIORS, ACES, PROVE-IT, ACTION, and the HF-ACTION trial. Eur J Heart Fail. 2004 Oct;6(6):787-91. Coletta AP, Cleland JG, Freemantle N, Clark AL. Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy. Eur J Heart Fail. 2004 Aug;6(5):673-6. Muntwyler J, Cohen-Solal A, Freemantle N, Eastaugh J, Cleland JG, Follath F. Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe. Eur J Heart Fail. 2004 Aug;6(5):663-8. 24
    • Witte KK, Clark AL. The effect of aspirin on the ventilatory response to exercise in chronic heart failure. Eur J Heart Fail. 2004 Oct;6(6):745-8. Clark AL, Morice A. Efficacy of a homeopathic Crataegus preparation. Eur J Heart Fail. 2004 Jun;6(4):511; discussion 517-8; author reply 519. Cleland JG, Ghosh J, Freemantle N, Kaye GC, Nasir M, Clark AL, Coletta AP. Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO- Lipids and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail. 2004 Jun;6(4):501-8. Banerjee P, Clark AL, Nikitin N, Cleland JG. Diastolic heart failure. Paroxysmal or chronic? Eur J Heart Fail. 2004 Jun;6(4):427-31. Cleland JG, Freemantle N, Kaye G, Nasir M, Velavan P, Lalukota K, Mudawi T, Shelton R, Clark AL, Coletta AP. Clinical trials update from the American Heart Association meeting: Omega-3 fatty acids and arrhythmia risk in patients with an implantable defibrillator, ACTIV in CHF, VALIANT, the Hanover autologous bone marrow transplantation study, SPORTIF V, ORBIT and PAD and DEFINITE. Eur J Heart Fail. 2004 Jan;6(1):109-15. Cleland JG, Torp-Pedersen C, Coletta AP, Lammiman MJ. A method to reduce loss to follow-up in clinical trials: informed, withdrawal of consent. Eur J Heart Fail. 2004 Jan;6(1):1-2. Cleland J.G.F., Goode K. Natriuretic peptides for heart failure. Fashionable? Useful? Necessary? Eur J Heart Failure 2004; 6:253-255 2003 Coletta AP, Cleland JG, Freemantle N, Loh H, Memon A, Clark AL. Clinical trials update from the European Society of Cardiology: CHARM, BASEL, EUROPA and ESTEEM. Eur J Heart Fail. 2003 Oct;5(5):697-704. Louis AA, Turner T, Gretton M, Baksh A, Cleland JG. A systematic review of telemonitoring for the management of heart failure. Eur J Heart Fail. 2003 Oct;5(5):583-90. Coletta AP, Clark AL, Seymour AM, Cleland JG. Clinical trials update from the European Society of Cardiology Heart Failure meeting: COMET, COMPANION, Tezosentan and SHAPE. Eur J Heart Fail. 2003 Aug;5(4):545-8. Cleland JG, Coletta AP, Nikitin N, Louis A, Clark A. Update of clinical trials from the American College of Cardiology 2003. EPHESUS, SPORTIF-III, ASCOT, COMPANION, UK-PACE and T-wave alternans. Eur J Heart Fail. 2003 Jun;5(3):391-8. Cleland JG, Freemantle N, Ball SG, Bonser RS, Camici P, Chattopadhyay S, utka D, Eastaugh J, Hampton J, Large S, Norell MS, Pennell DJ, Pepper J, Sanda S, Senior R, Smith D. The heart failure revascularisation trial (HEART): rationale, design and methodology. Eur J Heart Fail. 2003 Jun;5(3):295-303. 25
    • Cleland JG, Takala A, Apajasalo M, Zethraeus N, Kobelt G. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low- output heart failure: an analysis based on the international LIDO trial. Eur J Heart Fail. 2003 Jan;5(1):101-8. Coletta AP, Nikitin N, Clark AL, Cleland JG. Clinical trials update from the American Heart Association meeting: PROSPER, DIAL, home care monitoring trials, immune modulation therapy, COMPANION and anaemia in heart failure. Eur J Heart Fail. 2003 Jan;5(1):95-9. 2002 Louis AA, Manousos IR, Coletta AP, Clark AL,Cleland JGFC/GP. Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH. Eur J Heart Fail 2002; 4 (1): 111-6. Witte KK, Clark AL. Is the elevated slope relating ventilation to carbon dioxide production in chronic heart failure a consequence of slow metabolic gas kinetics? Eur J Heart Fail. 2002 Aug;4(4):469-72. Cleland J, How to assess new treatments for the management of heart failure: composite scoring systems to assess the patients' clinical journey. Eur J Heart Fail. 2002 Jun;4(3):243-7 Poole-Wilson PA, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Metra M, J Remme W, Swedberg K, Torp-Pedersen C, Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET. Eur J Heart Fail. 2002 Jun;4(3):321-9 Coletta A, Thackray S, Nikitin N, Cleland JG, Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL. Eur J Heart Fail. 2002 Jun;4(3):381-8 Thackray S, Easthaugh J, Freemantle N, Cleland JG, The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis. Eur J Heart Fail. 2002 Aug;4(4):515-29 Coletta AP, Clark AL, Banarjee P, Cleland JG, Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH. Eur J Heart Fail. 2002 Aug;4(4):559-61. Coletta AP, Louis AA, Clark AL, Nikitin N, Cleland JG, Clinical trials update from the European Society of Cardiology: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II. Eur J Heart Fail. 2002 Oct;4(5):661-6 26
    • 2001 Thackray S, Witte K, Khand A, Dunn A, Clark AL, Cleland JGF. Clinical Trial Update: Val HeFT, COPERNICUS, MERIT, CIBIS-II, BEST, AMIOVIRT, V-MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failure. Eur J Heart Fail 2001; 3: 117-124. Cleland JGF, Daubert JC Erdmann E, Freemantle N, Gras D, Kappenberger L, Klein W, Tavazzi L. On behalf of the CARE-HF Study Steering Committee and Investigators. The CARE-HF Study (Cardiac Resynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail 2001; 3: 481-489. Louis A, Cleland JGF, Crabbe S, Ford S, Thackray, S., Houghton T, Clark AL. Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001. Eur J Heart Fail 2001; 3: 381-387 Coletta AP, Cleland JGF. Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology – WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME. Eur J Heart Fail 2001; 3: 747-750. Cleland JGF. ACE Inhibitors for “Diastolic” Heart Failure? Reasons not to jump to premature conclusions about the efficacy of ACE inhibitors among older patients with heart failure. Eur J Heart Fail 2001; 3: 637-639. Thackray S, Coletta A, Jones P, Dunn A, Clark AL, Cleland JGF. Clinical trials update: highlights of the scientific sessions of heart failure 2001, a meeting of the working group on heart failure of the european society of cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF. Eur J Heart Fail 2001; 3:491-494. McGowan J, Martin W, Burgess M, McGurrach G, Ray SG, McDonagh T, Cleland JGF. Validation of an echocardiographic wall motion index in heart failure due to ischaemic heart disease. Eur J Heart Fail 2001; 3(6):731-737 J Appl Physiol (3.178) 2007 Clark AL. Increased mechanoreceptor/metaboreceptor stimulation explains the exaggerated exercise pressor reflex seen in heart failure. J Appl Physiol. 2007 Jan;102(1):500; author reply 504-5. (Letter) 2005 Banerjee P, Caulfield B, Crowe L, Clark A. Prolonged electrical muscle stimulation exercise improves strength and aerobic capacity in healthy sedentary adults. J Appl Physiol 2005;99:2307-11 Ann Emerg Med (3.120) 2003 27
    • Fletcher AK, Heyes FLP, Rigby AS. 3-in-1 femoral nerve block as analgesia for fractured neck of femur in accident and emergency: a randomised controlled trial. Ann Emerg Med 2003; 41 :227-233 Am J Cardiol (3.015) 2007 de Silva R, Loh PH, Rigby AS, Nikitin N P, Witte KK, Goode K, Bhandari S, Nicholson A, Clark AL, Cleland JG. Epidemiology, associated factors and prognostic outcomes of renal artery stenosis in chronic heart failure assessed by magnetic resonance angiography. Am J Cardiol 2007; Jul 15; 100(2): 273-9 [Epub 2007 Jun 6] Lainscak M, Cleland JG, Lenzen MJ, Keber I, Goode K, Follath F, Komajda M, Swedberg K. Nonpharmacologic measures and drug compliance in patients with heart failure: data from the EuroHeart Failure Survey. Am J Cardiol 2007 Mar 26; 99 (6B): 31D-37D. [Epub 2007 Jan 25] 2006 Witte KK, Clark AL. Resting left ventricular function, however measured, is poorly related to exercise capacity in chronic heart failure. Am J Cardiol. 2006 Sep 1;98(5):709-10. Epub 2006 Jul 5. de Silva R, Rigby AS, Witte KKA, Nikitin N P, Tin L, Goode K, Bhandari S, Clark AL, Cleland JGF. Anemia, Renal Dysfunction and their Interaction in Patients with Chronic Heart Failure. Am J Cardiol 2006; 98: 391-398. 2005 Lemos PA, Arampatzis CA, Hoye A, Daemen J, Ong ATL, Saia F, van der Giessen WJ, McFadden E, Sianos G, Smits PC, de Feyter P, Hofma SH, van Domburg RT, Serruys PW Impact of Baseline Renal Function on Mortality After Percutaneous Coronary Intervention with Sirolimus-Eluting Stents or Bare Metal Stents Am J Cardiol, 2005 Jan 15;95(2):167-72 Mollet N, Hoye A, Lemos P, Sianos G, Cadimitri F, Serruys PW, de Feyter P Value of Pre-Procedure Multislice CT Coronary Angiography to Predict Percutaneous Recanalization of Chronic Total Occlusions Am J Cardiol, 2005 Jan 15;95(2):240-3 2004 Vijayakumar M, Lemos PA, Hoye A, Ong ATL, Aoki J, Rodriguez Granillo G, McFadden EP, Sianos G, Hofma SH, Smits PC, van der Giessen WJ, de Feyter P, van Domburg RT, Cummins PA, Serruys PW Effectiveness of Sirolimus-Eluting Stent Implantation for the Treatment of Coronary Artery Disease in Octogenarians Am J Cardiol 2004 Oct 1;94(7):909-13 Lemos PA, Arampatzis CA, Saia F, Hoye A, Degertekin M, Tanabe K, Lee CH, Cummins P, Smits PC, McFadden E, Sianos G, de Feyter P, van der Giessen WJ, van 28
    • Domburg RT, Serruys PW Treatment of Very Small Vessels with 2.25-mm Diameter Sirolimus-Eluting Stents (from the RESEARCH Registry) Am J Cardiol 2004 Mar 1;93(5):633-6 Degertekin M, Arampatzis CA, Lemos PA, Saia F, Hoye A, Daemon J, Tanabe K, Lee CH, Hofma SJ, Sianos G, McFadden E, van der Giessen W, Smits PC, deFeyter PJ, van Domburg RT, Serruys PW Very Long Sirolimus-Eluting Stent Implantation for de novo Coronary Lesions Am J Cardiol 2004 April 1;93(7):826-9 Regar E, Lemos PA, Degertekin M, Saia F, Tanabe K, Lee CH, Arampatzis CA, Hoye A, Sianos G, deFeyter P, can der Giessen WJ, Smits PC, van Domburg R, Serruys PW Incidence of Thrombotic Stent Occlusion During the First 3 Months After Sirolimus-eluting Stent Implantation in 500 Consecutive Patients Treated in the Real World Am J Cardiol 2004 May, 15;93(10):1271-5 Tanabe K, Hoye A, Lemos PA, Aoki J, Arampatzis CA, Saia F, Lee CH, Degertekin M, Sianos G, Smits PC, van der Giessen WJ, de Feyter P, van Domburg RT, Serruys PW Restenosis Rates Following Bifurcation Stenting with Sirolimus-Eluting Stents for De Novo Narrowings Am J Cardiol, 2004 Jul 1;94(1):115-8 Hoye A, Lemos PA, Arampatzis CA, Saia F, Tanabe K, Degertekin M, Daemen J, Smits PC, McFadden E, Hofma SJ, Sianos G, de Feyter P, van der Giessen WJ, van Domburg RT, Serruys PW Effectiveness of Sirolimus-Eluting Stent Implantation for Coronary Narrowings <50% in Diameter Am J Cardiol, 2004 July 1;94(1):112-4 2003 Arampatzis CA, Lemos PA, Tanabe K, Hoye A, Degertekin M, Saia F, Lee CH, Ruiter A, McFadden E, Sianos G, Smits PC, van der Giessen WJ, de Feijter P, van Domburg R, Serruys PW Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease. Am J Cardiol. 2003 Aug 1;92(3):327-9 . Saia F, Lemos PA, Sianos G, Degertekin M, Lee CH, Arampatzis CA, Hoye A, Tanabe K, Regar E, van der Giessen WJ, Smits PC, de Feyter P, Ligthart J, van Domburg RT, Serruys PW Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy. Am J Cardiol. 2003 Jul 15;92(2):2003 2002 Nikitin NP, Witte KK, Clark AL, Cleland JG, Color tissue Doppler-derived long-axis left ventricular function in heart failure with preserved global systolic function. Am J Cardiol. 2002 Nov 15;90(10):1174-7 Med Sci Sports Ex (2.909) 2007 Ingle L, Carroll S. The 6-min walk test; a useful test in elderly patients with heart failure? Med Sci Sports Ex 2007 Feb; 39(2): 391. author reply 392. 29
    • Heart Failure Reviews 2007 Ingle L. Theoretical rationale and practical recommendations for cardiopulmonary exercise testing in patients with chronic heart failure. Heart Fail Rev 2007 Mar; 12(1) 12-22. [Epub ahead of print Mar 28). Curr Opin Cardiol (2.797) 2002 Cleland JG, McGowan J. Levosimendan: a new era for inodilator therapy for heart failure?. Curr Opin Cardiol 2002; 17(3):257-65 J Orthop Res (2.784) 2006 Ali AM, Saleh M, Eastell R, Wigderowitz CA, Rigby AS, Yang L. Influence of bone quality on the strength of internal and external fixation of tibial plateau fractures. J Orthop Res 2006; pp 2080-2086. QJM-Int J Med (2.770) 2004 Shelton RJ, Kaye GC, Cleland JG. Controlling persistent atrial fibrillation. QJM. 2004 Mar;97(3):179-80. J Card Fail (2.737) 2008 Goode KM, Nabb S, Cleland JG, Clark AL. A comparison of patient and physician- rated New York Heart Association class in community-based heart failure clinic. J Card Fail Jun; 14(5): 379-387. 2007 Torp-Pedersen C, Metra M, Spark P, Lukas MA, Moullet C, Scherhag A, Komajda M, Cleland JG, Remme W, Di Lenarda A, Swedberg K, Poole-Wilson P A, COMET Investigators. The safety of amiodarone in patients with heart failure. J Card Fail 2007; Jun; 13(5): 340-5. Damman K, Navis G, Voors AA, Asselbergs FW, Smilde TD, Cleland JG, van Veldhuisen D, Hillege HL. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 2007 (Oct); 13(8): 599-608. Review 2006 Metra M, Cas LD, Cleland JG. Pharmacokinetic and Pharmacodynamic characteristics of beta-blockers: when differences may matter. J Card Fail 2006 Apr; 12 (3): 177-81. 30
    • 2005 Ingle L, Shelton R, Cleland JGF, Clark AL. Poor relationship between exercise capacity and spirometric measurements in patients with more symptomatic heart failure. J Card Fail; 2005 Oct;11(8):619-23. Ekman I, Cleland JG, Swedberg K, Charlesworth A, Metra M, Poole-Wilson PA. Symptoms in patients with heart failure are prognostic predictors: insights from COMET. J Card Fail. 2005 May;11(4):288-92. Erratum in: J Card Fail. 2005 Jun;11(5):404 Clark AL, Cleland JG. Beta-blockers, exercise, and ventilation in chronic heart failure. J Card Fail. 2005 Jun;11(5):340-2. No abstract available Witte KK, Clark AL. Beta-blockers and inspiratory pulmonary function in chronic heart failure. J Card Fail. 2005 Mar;11(2):112-6. 2004 Zile M, Gaasch W, Little W, Francis G, Tavazzi L, Cleland J, Davies M;MCC-135 GO1 Investigators. A phase II, double-blind, randomized, placebo-controlled, dose comparative study of the efficacy, tolerability, and safety of MCC-135 in subjects with chronic heart failure, NYHA class II/III (MCC-135-GO1 study): rationale and design. J Card Fail. 2004 Jun;10(3):193-199. Witte KK, Morice A, Cleland JG, Clark AL. The reversibility of increased airways resistance in chronic heart failure measured by impulse oscillometry. J Card Fail. 2004 Apr;10(2):149-54. Massie BM, Krol WF, Ammon SE, Armstrong PW, Cleland JG, Collins JF, Ezekowitz M, Jafri SM, O'Connor CM, Packer M, Schulman KA, Teo K, Warren S. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. J Card Fail. 2004 Apr;10(2):101-12. 2003 Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis DP, Coats AJ, Clark AL, Anker SD. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail. 2003 Feb;9(1):29-35. 2002 Witte KK, Morice A, Clark AL, Cleland JG, Airway resistance in chronic heart failure measured by impulse oscillometry. J Card Fail. 2002 Aug;8(4):225-31 Nat Clin Pract Cardiovasc Med (2.723) 2007 31
    • Cleland JG, Nasir M, Tageldien A. Cardiac resynchronization therapy or atrio- biventricular pacing – what should it be called? Nat Clin Pract Cardiovasc Med. 1007 Feb; 4(2): 90-101. Br J Clin Pharmacol (2.718) 2004 Morant SV, McMahon AD, Cleland JG, Davey PG, MacDonald TM. Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity.Br J Clin Pharmacol. 2004 Feb;57(2):188-98. Prog Cardiovasc Dis (2.492) 2002 Cleland JGF. Is Aspirin ‘The Weakest Link’ in Cardiovascular ProphylaxisThe Surprising Lack of Evidence Supporting the Use of Aspirin for Cardiovascular Disease. Prog Cardiovasc Dis 2002; 44 (4): 275-292. 2001 Cleland JGF, Alamgir F, Nikitin N, Clark A, Norell M. What is the optimal medical management of ischaemic heart failure? Prog Cardiovasc Dis 2001; 43: 433-455. Resuscitation (2.314) 2007 Garg S, Perez L, Griffin S. Painless Type A aortic dissection presenting as complete heart block. Resuscitation. 2007 Jul 16; [Epub ahead of print] Int J Cardiol (2.234) 2008 Goode KM, Clark AL, Cleland JG. Ruling out heart failure in primary-care: the cost- benefit of pre-screeing using NT-proBNP and QRS width. Int J Cardiol 2008 Jan 4: [Epub ahead of print] 2007 Witte KK, Ford SJ, Preston T, Parker JD, Clark AL. Fibrinogen synthesis is increased in cachectic patients with chronic heart failure. Int J Cardiol 2007 Nov 15; [Epub ahead of print] Ingle L, Goode K, Carroll S, Sloan R, Boyes C, Cleland JGF, Clark AL. Prognostic value of the VE/VCO2 slope calculated from different time intervals in patients with suspected heart failure. Int J Cardiol 2007 Jun 12; 118(3) : 350-5 [Epub ahead of print Oct 2006]. 32
    • Ingle L, Witte K.K.A, Cleland J.G.F, Clark A.L., Prognostic value of cardiopulmonary exercise tests with a peak respiratory exchange ratio <1.0 in patients with chronic heart failure. Int J Cardiol 2007; Aug 13; [Epub ahead of print]. Carroll S, Marshall P, Borkoles E, Ingle L, Barker D, Tan LB. Efficacy of lifestyle intervention on peak exercise cardiac power output and reserve in pre-menopausal obese females: A randomised pilot study. Int J Cardiol 2007; Jul 10: 119(2): 147-55. [Epub ahead of print Jan 25] . 2006 Nikitin,N.P, Loh,H, de Silva,R, Witte,K,K,A, Lukaschuk,E, Parker A, Farnsworth,A, Alamgir,F, Clark,A.L, Cleland,J.G.F. Left ventricular morphology, global and longitudinal function in normal older individuals: a cardiac magnetic resonance study. Int J Cardiol 2006; 108: 76-83. 2005 Banerjee P, Clark AL, Norell MS. Repeat thrombolysis for acute myocardial infarction. Int J Cardiol. 2005 Jul 20;102(3):515-9 Ghosh J, Freemantle N, Cleland J. Meta-analysis does not show that cardiac resynchronization reduces all-cause mortality. Int J Cardiol. 2005 Aug 18; 103(2): 230-1 author reply 232-3. 2002 Witte KK, Clark AL. Nutritional abnormalities contributing to cachexia in chronic illness. Int J Cardiol. 2002 Sep;85(1):23-31. Review. Rev Esp Cardiol (2.176) 2006 Cleland JGF. Papel de los ARA-II en el tratamiento de la insuficiencia cardiaca: “qué dicen las guias de practica clinica? (Role of angiotensin receptor blockers in the treatment of chronic heart failure: What do the clinical practice guidelines say?) Rev Esp Cardio 2006; 6(Supl): 58C-72C. 2005 Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA. Guidelines for the Diagnosis and Treatment of Chronic Heart Failure: Executive Summary (Update 2005) Rev Esp Cardiol 2005 Sep; 58 (9): 1062-1092. English, Spanish. Arch Dis Child (2.090) 2002 Madlom MM, Singh R, Rigby AS. Assessment of acute admissions by Middle Grade and Consultants (Letter). Arch Dis in Childhood 2002: 87: 357-358 33
    • Am J Med Genet (A) (2.063) 2008 Worthington J, Rigby AS, Quarrell OJW. Seizure frequency in adults with Wolf- Hirschhorn syndrome. Am J Med Genet (A) 2008 (in press). Am J Man Care (2.060) 2003 Schwartz JS, Wang YR, Cleland JG, Gao L, Weiner M, Poole-Wilson PA; ATLAS Study Group. High- versus low-dose angiotensin converting enzyme inhibitor therapy in the treatment of heart failure: an economic analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial. Am J Manag Care. 2003 Jun;9(6):417-24. Med Clinics North Am (2.054) 2003 Cleland JG. Beta-blockers for heart failure: why, which, when, and where. Med Clin North Am. 2003 Mar;87(2):339-71. Eur J Cardiovasc Prev Rehab (1.979) 2004 Witte KK, Clark AL. Fish oils--adjuvant therapy in chronic heart failure? Eur J Cardiovasc Prev Rehabil. 2004 Aug;11(4):267-74. Palliative Medicine (1.939) 2007 Lambert K, Oxberry S, Hulme CW, Saharia K, Rigby AS, Johnson MJ. Knowledge and attitudes to opioids in palliative care patients. Palliative Medicine 2007 ; 21: 721-722. (letter) 2005 Clare C, Royle D, Saharia, Pearse H, Oxberry S, Oakley K, Allsopp L, Rigby AS, Johnson MJ. Painful bone metastases: a prospective observational cohort study. Palliative Medicine 2005; 19: 521-525. Brit J Gen Pract (1.938) 2003 Summerton N, Rigby AS, Mann S, Summerton A. The general practitioner - patient consultation pattern as a tool for cancer diagnosis in general practice. Br J Gen Pract 2003; 53: 50-52. 2002 34
    • Summerton N, Mann S, Rigby AS, Ashley J, Palmer S, Hetherington JW. Patients with new onset haematuria attending an "open-access" clinic: assessing the discriminant value of items of clinical information in relation to urological malignancies. Br J Gen Pract 2002: 52: 284-289 Int J Geriatr Psych (1.930) 2007 Haworth JE, Moniz-Cook E, Clark AL, Wang M, Cleland JGF. An evaluation of two self-report screening measures for mood in an out-patient chronic heart failure population. Int J Ger Psychiatry 2007: Nov;22(11):1147-53. [Apr 25 Epub ahead of print] Age and Ageing (1.919) 2005 Nikitin NP, Witte KKA, Ingle L, Clark AL, Farnsworth TA, Cleland JGF. Longitudinal myocardial dysfunction in healthy older subjects as a manifestation of cardiac ageing. Age and Ageing 2005,34:343-349 Brit Med Bulletin (1.881) 2001 Cleland,J.G.F., John J, Dhawan J, Clark AL. What is the optimal medical management of ischaemic heart failure? Brit Med Bulletin 2001; 59: 135-158 J Sports Sci (1.797) 2006 Ingle L, Sleap M, Tolfrey K. The effect of a complex training and detraining programme on selected strength and power variables in early pubertal boys. J Sports Sci 2006; 24 (9):987-97. Cardiology (1.795) 2004 Nikitin NP, Witte KK. Application of tissue Doppler imaging in cardiology. Cardiology. 2004;101(4):170-84. Epub 2004 Feb 12. (Review) J Bone Joint Surg Br (1.790) 2003 Donnan LT, Saleh M, Rigby AS. Acute deformity correction and simultaneous lengthening with a monolateral fixator. Brit J Bone and Joint Surg 2003: 85: 254-260 35
    • Patient Education and Counselling (1.778) 2005 Ekman I, Andersson G, Boman K, Charlesworth A, Cleland JG, Poole-Wilson P, Swedberg K. Adherence and perception of medication in patients with chronic heart failure during a five year randomized trial. Patient Education and Counselling; 2005: Aug 30 [Epub ahead of print] J Cardiovas Magn Reson (1.739) 2005 Prest C, Phillips R, Cleland JGF, Nikitin NP, Langton CM Automated left ventricular cardiac MRI segmentation, quantification and visualisation using a radial-ray approach. J Cardiovasc Magn Reson 2005 ;7: 327. Nikitin NP, Witte KKA, de Silva R, Thackray S, Loh PH, Lukaschuk E, Clark AL, Cleland JGF. Effect of optimal pharmacological treatment on left ventricular remodeling in chronic heart failure assessed by cardiovascular magnetic resonance . J Cardiovasc Magn Reson 2005 ;7: 25. Nikitin NP, Loh PH, de Silva R, Ghosh J, Lukaschuk E Clark AL Cleland JGF. Impaired aortic properties in patients with chronic heart failure as assessed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2005; 7: 34. Nikitin NP, Loh PH, Lukaschuk E, Cleland JGF. Chronic beta-blockade improves longitudinal left ventricular function in patients with chronic heart failure: a cardiac magnetic resonance study. J Cardiovasc Magn Reson 2005; 7: 128-129. 2004 Nikitin NP, de Silva R, Witte KKA, Lowe A, Lukaschuk E, Clark AL et al. Normal age- and sex-related values of left ventricular volumes, myocardial mass and ejection fraction obtained with cardiac magnetic resonance using FIESTA imaging. J Cardiovasc Magn Reson 2004; 6:163-164. Nikitin NP, de Silva R, Lowe A, Lukaschuk E, Cleland JGF. Relationship between global and longitudinal left ventricular function: a cardiac magnetic resonance study. J Cardiovasc Magn Reson 2004; 6:446-447. J Am Soc Echo (1.690) 2003 Nikitin NP, Witte KK, Thackray SD, de Silva R, Clark AL, Cleland JG. Longitudinal ventricular function: normal values of atrioventricular annular and myocardial velocities measured with quantitative two-dimensional color Doppler tissue imaging. J Am Soc Echocardiogr. 2003 Sep;16(9):906-21 Clin Radiol (1.665) 2007 36
    • Morris JE, Rickard S, Paley MN, Griffith PD, Rigby A, Whitby EN. The value of in- utero magnetic resonance imaging in ultrasound diagnosed foetal isolated cerebral ventriculomegaly. Clin Radiol 2007; 62: 140-144. Resp Med (1.663) 2001 Everard ML, Swarbrick A, Rigby AS, Milner AD The effect of ribavarin to treat previously healthy infants admitted with acute bronchiolitis and chronic respiratory morbidity. Resp Med 2001; 95: 275-280 BMC Public Health (1.658) 2006 Wormald H, Waters H, Sleap M, Ingle L. A lifestyle approach to promoting physical activity: Targeting deprived communities in Kingston-upon-Hull. BMC Public Health 2006; 6:202. J Aerosol Med (1.634) 2004 Aswania O, Ritson S, Iqbal SM, Bhat J, Rigby AS, Everard ML. Intra-subject variability in lung dose in healthy volunteers using five conventional portable inhalers. J Aerosol Med 2004 :17: 231-238 J Cardiovasc Pharmacol (1.625) 2005 Cleland JG, Sullivan JT, Ball S, Horowitz JD, Agoram B, Rosser D, Yates W,Tin L, Fuentealba P, Burton PB. Once-monthly administration of darbepoetin alfa for the treatment of patients with chronic heart failure and anemia: a pharmacokinetic and pharmacodynamic investigation. J Cardiovasc Pharmacol. 2005 Aug;46(2):155-61 Catheter Cardiovasc Interv. (1.569) 2006 Aoki J, Nakazawa G, Tanabe K, Hoye A, Yamamoto H, Nakayama T, Onuma Y, Higashikuni Y, Otsuki S, Yagishita A, Yachi S, Nakajima H, Hara K.Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv. 2006 Dec 28;69(3):380-386 [Epub ahead of print] Sianos G, Vaina S, Hoye A, Serruys PW.Bifurcation stenting with drug eluting stents: Illustration of the crush technique. Catheter Cardiovasc Interv. 2006 Jun;67(6):839-45. 37
    • 2005 Stone GW, Colombo A, Teirstein PS, Moses JW, Leon MB, Reifart NJ, Mintz GS, Hoye A, Cox DA, Baim DS, Strauss BH, Selmon M, Moussa I, Suzuki T, Tamai H, Katoh O, Mitsudo K, Grube E, Cannon LA, Kandzari DE, Reisman M, Schwartz RS, Bailey S, Dangas G, Mehran R, Abizaid A, Serruys PW. Percutaneous recanalization of chronically occluded coronary arteries: Procedural techniques, devices, and results Catheter Cardiovasc Interv. 2005 Oct;66(2):217-236 2004 Hoye A, Onderwater E, Cummins P, Sianos G, Serruys PW Improved Recanalization of Chronic Total Coronary Occlusions Using an Optical Coherence Reflectometry- Guided Guidewire. Catheter Cardiovasc Interv 2004 Oct;63(2):158-63 Arampatzis CA, Hoye A, Lemos PA, Saia F, Tanabe K, Degertekin M, Sianos G, Smits PC, van der Giessen WJ, McFadden E, van Domburg R, de Feyter P, Serruys PW. Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis: one-year clinical outcomes of 99 consecutive patients - the Rotterdam experience. Catheter Cardiovasc Interv. 2004 Sep;63(1):57-60. Saia F, Lemos PA, Hoye A, Sianos G, Arampatzis CA, de Feyter PJ, van der Giessen WJ, Smits PC, van Domburg RT, Serruys PW Clinical Outcomes for Sirolimus-Eluting Stent Implantation and Vascular Brachytherapy for the Treatment of In-stent Restenosis Catheter Cardiovasc Interv 2004 July;62(3):283-8 Sianos G, Hofma S, Ligthart JM, Saia F, Hoye A, Lemos PA, Serruys PW Stent fracture and restenosis in the drug-eluting stent era. Catheter Cardiovasc Interv. 2004 Jan;61(1):111-116. Saia F, Lemos PA, Arampatzis CA, Hoye A, McFadden E, Sianos G, Smits PC, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW Clinical and Angiographic Outcomes after Overdilation of Undersized Sirolimus-Eluting Stents with Largely Oversized Balloons: an Observational Study Catheter Cardiovasc Interv 2004 April;61(4): 455-60 Family Practice (1.558) 2003 Summerton N, Mann S, Sutton J, Rigby A, Theakston A, Clark J, Williams-Hardy H, Summerton A. Developing clinically relevant and reproducible symptom-defined populations for cancer diagnostic research in general practice using a community survey. Family Practice ; 2003: 20: 340-346 2001 Summerton N, Mann S, Rigby A, Petkar S, Dhawan J. New onset palpitations in general practice: assessing the discriminant value of items within the clinical history. Family Practice 2001; 18: 383-392 J Public Health Med (1.527) 38
    • 2001 Hall DMB, Rigby AS, Bowns IR, Williams TS, Crofts D. Births, gestation and birthweights in South Tees 1990-1996 (Letter). J Pub Health Med 2001: 23: 253-254 Coron Artery Dis (1.507) 2004 Lemos PA, Hoye A, Serruys PW Recurrent Angina after Revascularization: an Emerging Problem for the Clinician Coron Artery Dis 2004 Jun;15(4):S11-5 Hoye A, Lemos PA, Arampatzis CA, Saia F, Tanabe K, Degertekin M, Hofma SH, McFadden E, Sianos G, Smits PC, van der Giessen WJ, de Feyter P, van Domburg RT, Serruys PW Effectiveness of the Sirolimus-eluting Stent in the Treatment of Patients with a Prior History of Coronary Artery Bypass Graft Surgery Coron Artery Dis 2004 May;15(3):171-175 Clinical Rehabilitation (1.500) 2006 Ryan T, Enderby P, Rigby AS. A randomized controlled trial to evaluate intensity of community based rehabilitation provision following stroke or hip fracture in old age. Clin Rehab 2006; 20: 123-131 . Europace (1.477) 2007 Authors/Task Force Members, Vardas PE, Auricchio A, Blanc JJ,Daubert JC, Drexler H, Ector H, Gasparini M, Linde C, Morgado FB, Oto A, Sutton R,Trusz- Gluza M; ESC Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL; Document Reviewers, Priori SG, Blomstrom-Lundqvist C, Brignole M, Terradellas JB, Camm J, Castellano P, Cleland J, Farre J, Fromer M, Le Heuzey JY, Lip GY, Merino JL, Montenero AS, Ritter P, Schalij MJ, Stellbrink C. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association. Europace. 2007 Aug 28; [Epub ahead of print] No abstract available. Gras D, Böcker D, Lunati M, Wellens HJJ, Calvert M, Freemantle N, Gervais R, Kappenberger L, Tavazzi L, Erdmann E, Cleland JG, Daubert J-C on behalf of The CARE-HF Study Steering Committee and Investigators Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. Europace 2007 Jul 9(7):516-22. [Epub 2007 May 31] 39
    • Shelton R, Goode K, Cleland JGF. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro) BNP. (Letter) . Europace 2007 Feb ;9(2): 147. [Epub 2007 Jan 16] (Letter) Kaye G, Edgar D, Mudawi T, Lippert M, Czygan G. Can transventricular intrqcardiac impedance measurement discriminate haemodynamically unstable ventricular arrhythmias in humans? Europace 2007 Feb; 9 (2): 122-6. 2006 Khand AU, Rankin AC, Cleland JG, Gemmell I, Clark E, Madfarlane PW. The assessment of autonomic function in chronic atrial fibrillation: description of a non- invasive technique based on circadian rhythm of atrioventricular nodal functional refractory periods. Europace 2006 Nov; 8(11): 927-34. Kaye G, Arthur W, Edgar D, Lippert M, Czygan G. The use of unipolar intracardiac impedance for discrimination of haemodynamically stable and unstable arrhythmias in man. Europace 2006 Nov; 8 (11): 988-93. Shelton RJ, Allinson A, Johnson T, Smales C, Kaye GC. Four years experience of a nurse-led elective cardioversion service within a district general hospital setting. Europace 2006 Jan; 8 (1) : 81-5. Cardiovasc Drugs Ther (1.396) 2004 Cleland JG, Goode K, Erhardt L, Remme WJ, Charlesworth A, Poole-Wilson PA, Di Lenarda A, Hanrath P, Komajda M, Metra M, Swedberg K, Torp-Pedersen C; Carvedilol or Metoprolol European Trial Investigators. A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET).Cardiovasc Drugs Ther. 2004 Mar;18(2):139-52. J Adv Nurs (1.342) 2005 Mason S, Fletcher A, McCormick S, Perrin J, Rigby A. Developing assessment of emergency nurse practitioner competence - a pilot study. J Advan Nursing 2005: 50: 425-432 Acta Paediatr (1.297) 2003 Aswani N, Taylor CJ, McGaw J, Pickering M, Rigby AS. Pubertal growth and development in cystic fibrosis: a retrospective review. Acta Paediatrica 2003: 92: 1029-1032 Clin Med (1.295) 40
    • 2008 Murphy JJ, Chakraborty R, Fuat A, Davies MK, Cleland JGF. Diagnosis and management of patients with heart failure in England. Clin Med 2008 Jun; 8 (3) : 264-266. 2007 Garg S, Saha A, Clark A. Is sensible use being made of an inpatient Holter monitoring and transthoracic echocardiogram service within acute medicine? Clin Med. 2006 Nov Dec;6(6):586-91. Br J Radiol (1.279) 2002 Arthur WR, Dhawan J, Norell MS, Hunter AJ, Clark AL. Does cardiologist- or radiographer-operated fluoroscopy and image acquisition influence optimization of patient radiation exposure during routine coronary angiography? Br J Radiol. 2002 Sep;75(897):748-53. Acta Paediatrica (1.277) 2007 Elphick HE, Ritson S, Rigby AS, Everard ML. Phenotype of acute respiratory syncytial virus induced lower respiratory tract illness in infancy and subsequent morbidity. Acta Paediatrica 2007;(96)2:307-309. Int J Sports Med (1.240) 2007 Ingle L, Wilkinson M, Carroll S, Boyes C, Cleland JGF, Clark AL. Cardiorespiratory requirements of the 6-min walk test in patients with left ventricular systolic dysfunction and no major structural heart disease. Int J Sports Med 2007; Aug; 28(8): 678-84 [Apr 13 Epub ahead of print.]. Int J Clin Pract (1.188) 2004 Hashmi MA, Tellisi N, Rigby AS, Wahab KHA. The value of a prognostic scoring system in the rehabilitation of elderly patients with proximal femoral fractures. Int J Clin Pract 2004; 58: 2-5 Disability and Rehabilitation (1.164) 2008 Rigby AS. Statistical Reviewing for Disability and Rehabilitation. Disabil Rehabil 2008 (in press). 41
    • 2006 Connelly J, Chell S, Tennant A, Rigby AS, Airey CM. Modelling 5-year functional outcome in a major traumatic injury survivor cohort. Disabil Rehabil 2006; 28(10): 629-636. 2005 Rigby AS, Summerton N. Statistical methods in epidemiology. VIII. On the use of likelihood ratios for diagnostic testing with an application to general practice. Disabil Rehabil 2005: 27;9: 475-480 (Review) 2001 Rigby AS. Statistical methods in epidemiology. VII. An overview of the χ2 test for goodness-of-fit. Disabil Rehabil 2001; 23: 693-697 Airey CM, Chell S, Rigby AS, Tennant A, Connelly J. The epidemiology of disability and occupational handicap resulting from major traumatic injury Disabil Rehabil 2001: 23: 509-515 J Interv Card Electrophysiol (1.084) 2006 Cleland JGF, Velavan P, Nasir M. Fighting Against Sudden Death: A Single or Multidisciplinary Approach. J Interv Card Electrophysiol 2006: 17 (3): 205-10 [Epub 2007 Apr 6] Clin Cardiol (0.989) 2008 Loh PH, Cleland JG, Louis AA, Kennard ED, Cook JF, Caplin JL, Barsness GW,Lawson WE, Soran OZ, Michaels AD. Enhanced External Counterpulsation in the Treatment of Chronic Refractory Angina:A Long-term Follow-up Outcome from the International Enhanced External Counterpulsation Patient Registry. Clin Cardiol. 2008 Apr;31(4):159-64. Emerg Med J (0.869) 2004 Locker T, Mason S, Rigby A. Headache management: are we doing enough? An observational study of patients presenting with headache to the emergency department. Emerg Med J 2004 :21: 327-332 42
    • J Pediatr Orthop B. (0.534) 2007 McAndrew AR, Saleh M, Rigby AS, Donnan LT. The radiographic classification of the bone-screw interface in paediatric tibial lengthening. J Pediatr Orthop B. 2007; 16(5) Sep: 305-311. Dis Manag Health Out (0.385) 2006 Cleland JGF. The Trans-European Network - Home-Care Management System (TEN- HMS) Study: An Investigation of the Effect of Telemedicine on Outcomes in Europe. Dis Manag Health Out 2006; 14(1):1-6. Kardiologya (0.145) 2002 Nikitin NP, Cleland JG, Use of myocardial tissue Doppler imaging in cardiology, Kardiologiia. 2002;42(3):66-79 Whole Books Cleland JGF. Understanding Heart Failure Pub Family Doctor Publications (London) 2005 Update in Press. Cleland JGF, MacFadyen RJ. An Illustrated Guide to Heart Failure. Pub: Current Medical Literature (London). 2002 Cleland JGF, Williams H, Davis M (Editorial Advisers). Formulary Focus. A Prescriber Guide to Rational Drug Choice. ACE Inhibitors. Pub: Interface Communications – a division of A&M Publishing Ltd., Guildford (2001) Chapters in Books Cleland JGF. The epidemiology of heart failure. In: Supportive Care in Heart Failure. 2008. Ed: Beattie J, Goodlin S. Pub.Oxford University Press (Oxford). Chapter 1; pp 9-25 43
    • Cleland JGF, Coletta AP, Witte KKA, Clark AL. Men’s Health: heart failure. In: Men’s Health (3rd Edition). 2008. (Nov) In Press: Ed: Kirby RS, Carson CC, Kirby MG, Farah RN. Pub. Taylor & Francis (London). Cleland JGF, Loh H. Angiotensin II Receptor Blockers for Chronic Heart Failure. In: Angiotensin II Receptor Antagonists (2nd Edition) Ed: Mancia G. Pub Taylor & Francis, Oxford. (in press) Cleland JGF. Classification Of The Level Of Evidence In International Guidelines For Acute And Chronic Heart Failure. In: Acute Heart Failure. Ed: Mebazaa A, Gheorghiade M, Zannad FM, Parrillo JE. Springer-Verlag, London. 2008. Section 2.10, Chapter 82: pp 885-892. Cleland JGF, Khan NK, Hobson N, Nasir M. Nikitin N, Tageldien A, Clark A. Cardiac Resynchronization Therapy. In: Atlas of Heart Failure. 5th ed., Ed Colucci WS. Current Medicine Group (A division of Springer), Philadelphia. Nov 2007. Chapter 12, pp 207-225. Cleland JGF. Heart Failure. In: Ischaemic Heart Disease. Ed: Falk E, Shah PK, de Feyter PJ. March 2007 Manson Publishing, London. Cleland JGF, Nikitin N, Ghosh J, Coletta AP, Memon A, Clark A. Angiotensin Receptor Blockers for Heart Failure. In: Heart Failure: A comprehensive guide to diagnosis and treatment. 2005: 277-318, Ed: Dec GW. Pub. Marcel Dekker, (New York) Cleland JGF, Loh H, Windram J. Are there Clinically Important Differences between Beta-Blockers in Heart Failure? In: Heart Failure Clinics: Neurohumoral Modulators in Heart Failure. 2005 (1) ;1: pp 57-66. Ed: Fonarow GC, Narula J, Young JB. Pub. Saunders (Philadelphia). Cleland JGF, Nikitin N, Ghosh J, Coletta AP, Memon A, Clark AL. Angiotensin receptor blockers for heart failure. Chapter in: Heart Failure: a comprehensive guide to diagnosis and treatment. Marcel Dekker, 2005 Clark AL. Pathophysiology of Cachexia: Neurohormonal factors. Chapter in: Pharmacotherapy of cachexia. CRC Press, 2005 Clark AL. Fatigue in Heart Disease. Chapter in: Handbook of fatigue. Haworth Press, 2005 Swedberg K, Cleland JGF The European Society of Cardiology Guidelines on Chronic Heart Failure. In: Braunwald 2005 …… (in press) Witte KKA, Clark AL. Micronutrients and heart disease. Chapter in: Nutrition and Heart Disease; CRC Press 2004 44
    • Cleland JGF, Coletta AP, Witte K, Clark AL. Men’s Health: Heart Failure. Chapter in: Men’s Health. Taylor and Francis, 2004. pp 111-144 Clark AL. Hypertension in children and young adults Chapter in: New Perspectives in Hypertension. Merit Publishing International, 2004. pp 102-9 Cleland JGF. Management of Thrombosis in Heart Failure. In: Heart Failure – A companion to Braunwald’s Heart Disease. 2004: pp 653-682. Ed: Mann D. Pub. Saunders (Philadelphia). Cleland JGF. Beta-blockers for heart failure. In: Horizons in Medicine. 2002 Ed. Amiel S. Royal Coll Phys (London) pp 13-38. Cleland JGF. Perindopril: A viewpoint. 2002 In: Drugs Adis International. Cleland JGF, MacFadyen RJ. An Illustrated Guide to Heart Failure. 2002 Pub: CurrentMedical Literature, London. Williams GH, Fitzpatrick R, MacGregor AJ, Rigby AS Rheumatoid arthritis. Chapter in: Experiencing and Explaining Disease: A Reader. 3rd Edition Ed: Davey B, Seale C 2002 Oxford Univ Press , Buckingham. pp 46-82 Cleland JGF, Williams H, Davis M (Editorial Advisers). Formulary Focus. A Prescriber Guide to Rational Drug Choice. ACE Inhibitors. 2001 Pub: Interface Communications – a division of A&M Publishing Ltd., Guildford Cleland JGF. The Future of Heart Failure Management. In: Ryden L, Editor. Prevention of Disease Progression Throughout the Cardiovascular Continuum: The role of adrenergic blockade. 2001 Springer-Verlag, Berlin pp 131-143 Clark AL The health benefits of physical activity for patients with chronic heart failure. Chapter In: Physical activity for patients. 2001 Royal College of Physicians London. Clark AL, McMurray JJV. Heart Failure: Diagnosis and Management. 2001. Martin Dunitz, London Journals without Impact Factor BMC Public Health 2006 45
    • Wormald H, Waters H, Sleap M, Ingle L. Participants’ perceptions of a lifestyle approach to promoting physical activity: targeting deprived communities in Kingston-upon-Hull. BMC Public Health. 2006 Aug 4;6:202. Br J Health Psychol 2006 Frizelle DJ, Lewin B, Kaye G, Moniz-Cook ED. Development of a measure of the concerns held by people with implanted cardioverter defibrillators: the ICDC. Br J Health Psychol 2006 May; 11 (Pt 2): 293-301. 2004 Frizelle DJ, Lewin RJ, Kaye G, Hargreaves C, Haney K, Beaumont N, Moniz-Cook E. Cognitive-behavioural rehabilitation programme for patients with an implanted cardioverter defibrillator: a pilot study. Br J Health Psychol 2004 Sep; 9(Pt 3): 381-92. Congestive Heart Failure 2008 Velavan P, Loh PH, Clark A, Cleland JG. Is the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) the answer to the cholesterol paradox in heart failure? Congest Heart Fail 2008 Jan-Feb; 14(1): 55. 2007 Velavan P, Loh PH, Clark AL, Cleland JGF. The Cholesterol Paradox in Heart Failure. Congest Heart Fail 2007; 13:336-341. Device Therapy For Heart Failure Tageldien A, Cullington D, Hurren S, Simpkin J, Cleland JGF. How Should Non- Responders to CRT be Managed? Device Therapy for Heart Failure 2008: 2(1):2-9 Eurointervention 2006 Hoye A. The How and why of chronic total occlusions: Why we treat CTOs the way we do. Eurointervention 2006;2:382-8 Hoye A, van Mieghem CA, Ong ATL, Aoki J, Rodriguez Granillo G, Valgimigli M, Tsuchida K, Sianos G, McFadden E, van der Giessen WJ, de Feyter P, Serruys PW. Treatment of De Novo Bifurcation Lesions: Comparison of Sirolimus- and Paclitaxel- Eluting Stents Eurointervention 2005;1:24-30 Hoye A, Ong ATL, Lemos PA, Aoki J, van Mieghem CA, Valgimigli M, Rodriguez Granillo G, Sianos G, McFadden E, van der Giessen WJ, de Feyter WJ, van Domburg RT, Serruys PW. Low Rates of Target Vessel Revascularization Following Drug- Eluting Stent Implantation for Chronic Total Occlusions: Comparison between the Sirolimus- and Paclitaxel-Eluting Stent Eurointervention 1:193-197 46
    • Heart Online Nicol ED, Fitall B, Roughton M, Cleland JGF, Dargie HJ, Cowie MR. NHS Heart Failure Survey - a survey of acute heart failure admissions in England, Wales and Northern Ireland. Heart Online doi: 10.1136/hrt2007.124107, 1-6. 2007. In Circulation.net Goode K, Kubanek M, Cleland JGF. The benefits of B-type natriuretic peptide testing in heart failure. In Circulation.net 2007 (April): http://www.incirculation.net/24174_87400.aspx Interventional Cardiology 2006 Garg S, Hoye A Percutaneous Coronary Interventions for de novo Bifurcation Lesions Interventional Cardiology September 2006:30-33 J Invasive Cardiol 2005 Ruiz-Cantador J, Hoye A, McFadden EP Multimodality Plaque Ablation following Failure of Conventional Wires and Balloons to Cross and to Allow Successful Paclitaxel-Eluting Stent Implantation of a Chronic Total Occlusion J Invasive Cardiol. 2005 Oct;17(10):E7-E10 Hoye A, Lemos PA, Serruys PW Successful use of a new guidewire with radiofrequency ablation capability for the treatment of chronic total occlusion at the ostium of the left anterior descending artery J Invasive Cardiol. 2005 May;17(5):277-9 Vijaykumar M, Rodriguez Granillo GA, Lemos PA, Aoki J, Hoye A, Ong AT, McFadden EP, Sianos G, Hofma SH, Smits PC, van der Giessen WJ, de Feyter P, van Domburg RT, Serruys PW Sirolimus-eluting stents for the Treatment of Atherosclerotic Ostial Lesions J Invasive Cardiol 2005 Jan;17(1):10-2, discussion 13. 2004 Daemon J, Lemos P, Aoki J, Arampatzis C, Hoye A, McFadden E, Serruys P Treatment of Coronary Artery Disease in Dialysis Patients with Sirolimus-Eluting Stent: 1-year Clinical Follow-up of a Consecutive Series of Cases J Invasive Cardiol 2004 Dec;16(12):658-7 Predictors of Survival after Contemporary Percutaneous Revascularization for Acute Myocardial Infarction in the Real World. Lee CH, van Domburg RT, Hoye A, Lemos 47
    • PA, Tanabe K, Smits PC, van der Giessen WJ, de Feyter P, Serruys PW. J Invasive Cardiol 2004 Nov;16(11):627-31 Hoye A, Lemos PA, Arampatzis CA, Saia F, Tanabe K, Degertekin M, Hofma SH, McFadden E, Sianos G, Smits PC, van der Giessen WJ, de Feyter P, van Domburg RT, Serruys PW Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease. J Invasive Cardiol 2004 May;16(5): 230-233 Saia F, Sianos G, Hoye A, Lemos PA, van der Giessen WJ, de Feyter P, van Domburg RT, Serruys PW Long-term Outcome of Percutaneous Coronary Intervention after Failed Brachytherapy J Invasive Cardiol 2004 Feb;16(2):60-4 Int J Cardiovasc Intervent 2004 Serruys P, Hoye A, Grollier G, Colombo A, Symons J, Mudra H.A European multi- center trial investigating the anti-restenotic effect of intravascular sonotherapy after stenting of de novo lesions (EUROSPAH: EUROpean Sonotherapy Prevention of Arterial Hyperplasia Int J Cardiovasc Intervent. 2004;6(2):53-60. J Interv Cardiol 2005 Aoki J, Hoye A, Staferov AV, Alekyan BG, Serruys PW Sirolimus-eluting stent implantation for chronic total occlusion of the left main coronary artery J Interv Cardiol. 2005 Feb;18(1):65-9 2004 Hoye A, van der Giessen WJ New Approaches to Ostial and Bifurcation Lesions J Interv Cardiol 2004 Dec;17(6):397-403. J Pediatr Orthoped 2007 Whitby EH, Bell MJ, Rigby AS, Burton M. Measuring hip development using MRI. J Pediatr Orthoped. 2007; In press. Pacing Clin Electrophysiol 2006 Kaye GC. Upgrading pacing generators in the era of biventricular pacing. Pacing Clin Electrophysiol 2006 Jul; 29 (7) : 689-90. 2004 John J, Kaye GC. Shock coil failure secondary to external irradiation in a patient with implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2004 May; 27 (5): 690-1. Pract Cardiovasc Risk Man 2007 48
    • Cleland JGF. What if I had heart failure? Pract Cardiovasc Risk Man 2007 ;5 (3) July: 5-8. Practitioner 2008 Witte KK, Clark AL. GPs have a pivotal role in managing CHF. Practitioner 2008 Jun; 252(1707): 29-30, 32, 34 passim. 2004 Mudawi TO, Kaye GC. Pacemakers: a guide for Gps. Practitioner 2004 Mar; 248 (1656): 164-8, 170, 172. 49